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Purpose: The purpose of this investigation was to examine the potential effects of 
SR2W-1 supplementation on cycling performance, central fatigue, and a variety of 
physiological parameters, including blood lactate, blood pH, heart rate (HR), rating of 
perceived exertion (RPE), oxygen consumption (VO2), expired ventilation (VE), and 
respiratory exchange ratio (RER). Methods: Five recreational cyclists (38 ± 8 yr, 168.4 ± 
4.3 cm, 68.8 ± 5.6 kg, and 54.4 ± 2.6 mL/kg/min) performed 20-min of steady-state 
cycling (~85% VO2max) followed by three 1-min high intensity intervals at VO2max with 
30-sec active recovery periods at 100 W, 15-min passive recovery period, and a ride to 
fatigue (or < 50 RPM) at VO2max.  Subjects were randomly assigned to receive either 
1000mg/d of SR2W-1 (EXP) or 1000mg/d placebo (PLA).  The supplement was 
distributed in a double-blind, crossover fashion.  The twenty-one day supplementation 
periods were separated by a 14-day “washout” period.  Change-scores from pre- to post- 
supplementation were calculated for all parameters, under both PLA and EXP conditions.  
Wilcoxon Signed-Rank Tests were utilized to compare change-scores between PLA and 
EXP conditions. Results: There were no differences between PLA and EXP for any of 
the dependent variables; however several variables approached significance (p < 0.1).  
Specifically blood glucose levels, HR and ventilation increased to a greater extent with 
EXP, compared to PLA throughout the 20-min ride and high intensity intervals. 
Conclusion: Notwithstanding the small sample size, 3 weeks of herbal supplementation 
(SR2W-1) does not appear to aid in cycling performance, attenuate skeletal muscle 






 A multitude of research regarding exercise physiology, focus on the manipulation 
of certain variables to optimize performance.  High intensity endurance performance (i.e. 
cycling and running) is naturally limited by factors that contribute to skeletal muscle 
fatigue.  In 1954, Merton proposed that fatigue results from inconsistent and inadequate 
blood supply to the working muscle.  The potential role of blood in the development of 
muscle fatigue is not limited to Merton‟s hypothesis but also includes exercise-induced 
variations in the concentration of certain blood parameters, namely hydrogen ions (pH) 
and lactate (22, 25, 27, 38, 40, 42).   
 Hermansen and Osnes were among the first to demonstrate the inverse 
relationship between pH (increase in hydrogen ion concentration) and exercise intensity 
(25).  When ATP demands become increasingly high, in accordance with exercise 
intensity, glycolysis generates pyruvate at rates that exceed pyruvate oxidative capacity.  
In this scenario, accumulating amounts of pyruvate are converted into lactic acid, which 
then disassociates into lactate and H
+
 ions (i.e. metabolic acidosis) (10, 51).  Despite 
these events, it has been suggested that proton accumulation during high intensity 
exercise results from ATP hydrolysis, not lactic acid formation (9, 10, 51, 59).  Although 
still unsettled, lactate dynamics of McArdle‟s disease patients exemplify the role that 
lactic acid plays in metabolic acidosis.  McArdle‟s patients are not able to metabolize 
muscle glycogen and consequently have a limited ability to produce lactic acid and 




Regardless of the derivation of the hydrogen ions, there is a clear directional 
relationship between exercise intensity, blood pH, and skeletal muscle function.  The 
direct impact that pH has on muscle performance is best illustrated by experimental 
manipulations of pH facilitated by the ingestion of ammonium chloride (NH4Cl) or 
sodium bicarbonate (NaHCO3), as the two treatments have opposite effects of blood pH 
buffering.  Skeletal muscle power output was impacted by both conditions.  Specifically, 
NaHCO3 ingestion enhanced muscle power output (increased pH), whereas NH4Cl 
impaired power output (decreased pH) (27).  Raymer et al. found that slight alterations in 
blood pH via induced alkalosis led to a longer time to exhaustion during progressive wrist 
flexions to fatigue (50).  Additionally, Lindh and colleagues reported significantly faster 
swimming time-trials for the 200-m freestyle with acute ingestion of sodium bicarbonate 
(200 mg/kg of body weight) 60-90 minutes prior to performance (36).  Denning et al. 
concluded that any decrement in HCO3 in the blood led to an impaired ability to buffer 
H
+
 ions during high intensity exercise (leading to acidosis and muscle fatigue) (17). 
While the general relationship between skeletal muscle performance and pH are 
clear (28), underlying mechanisms for this remain uncertain (52, 54).  In addition to the 
aforementioned peripheral factors that are known to inhibit muscle function, fatigue has 
also been correlated with neuromuscular dynamics (26).  Reductions in muscle fiber 
conduction velocity and motor drive have been linked to central nervous system fatigue 
(CNS) (45, 49).   Specifically, Racinais et al. was able to display a decrement in motor 
drive after repeated bouts of interval sprints, in addition to peripheral fatigue (49).  
However, in a state of induced alkalosis, both nerve/synapse activity and muscle fiber 




This finding suggests that fatigue is, to a greater extent, attributable to CNS fatigue rather 
than peripheral fatigue under these conditions (26, 60).  Specifically, elevated serum K
+
 
levels in a state of alkalosis improves muscle fiber conduction velocity, thereby 
preserving contractile properties in the sarcolemma (i.e. attenuation of central fatigue) 
(45).  Additionally, muscle fiber conduction velocity is sustained throughout prolonged 
submaximal cycling in a state of alkalosis, thus providing greater resistance to fatigue 
(26).  As for the portioning of central vs. peripheral fatigue, Kent-Braun demonstrated 
that there is a strong non-linear association between pH and force (r = 0.95), 20% of 
which is attributable to central fatigue, with the remaining attributed to peripheral fatigue 
(28).  However, it remains unclear whether central or peripheral fatigue is most effected 
by induced alkalosis, and if duration or intensity of exercise dictate the source of fatigue 
that is effected (52, 54). 
 Recently researchers have examined the possible ergogenic effects of herbal 
supplements that are in accordance with NCAA and IOC regulations and associated with 
minimal side effects.  As explained by L.R. Kleijnen et al. (30), ergogenic herbs are 
classified as adaptogens, which reportedly relieves central nervous system stress rather 
than providing a stimulatory effect, much like other ergogenic aids.  However, if taken in 
excess, herbal supplements may cause hypertension, irritability, insomnia and 
gastrointestinal distress (37).  Although not unanimous, some studies have demonstrated 
that herbal supplementation improves gains in muscular strength, maximal oxygen 
uptake, and lactate handling (11, 18, 31).  Various forms of ginseng and mushroom are 
some of the more popularly researched herbs, both of which are ingredients in 




lactate maintenance and exercise performance (1, 5, 31, 64).   Further, there have been at 
least two reports that SR2W-1 supplementation improves performance, in both humans 
and mice (1, 31).  The mechanism of action remains unclear and further research on 
herbal supplementation is warranted, and may be the key to exposing factors involved in 
muscle fatigue. 
 
Purpose of the Study 
The primary aim of this study was to examine the potential effects of 21-days of 
SR2W-1 supplementation on cycling performance, muscle fatigue, and various other 
physiological parameters (i.e. blood lactate, HR, RER, VE, VO2) with a randomized, 
double-blinded, crossover study design. 
 
Aims and Hypotheses 
Aim 1- To examine the impact of 21 consecutive days of SR2W-1 supplementation on 
high-intensity time to exhaustion cycling performance. 
Hypothesis 1- SR2W-1 supplementation will improve time to fatigue compared to a 
placebo supplement. 
Aim 2- To examine the impact of 21 consecutive days of SR2W-1 supplementation on 
blood lactate during 24 minutes of high-intensity cycling and after a high-intensity time 
to exhaustion performance. 
Hypothesis 2- SR2W-1 supplementation will elicit lower lactate levels during the cycling 




Aim 3- To determine the impact of 21 consecutive days of SR2W-1 supplementation on 
central nervous system (CNS) fatigue after 24 minutes of high-intensity cycling. 
Hypothesis 3- SR2W-1 supplementation will allow for better resistance to fatigue after a 
bout of high-intensity cycling, in comparison to a placebo supplementation. 
Aim 4- To determine the impact of 21 consecutive days of SR2W-1 supplementation on 
peripheral fatigue after 24 minutes of high-intensity cycling. 
Hypothesis 4- SR2W-1 supplementation will allow for better resistance to fatigue after a 
bout of high-intensity cycling, in comparison to a placebo supplementation. 
 
Significance 
The findings from this study will further our understanding of physiological 
mechanisms involved in fatigue during intense cycling exercise.  Recent research on 
athletic performance indicate that metabolic acidosis via anaerobic glycolysis, is at least a 
contributing factor to fatigue development.  A host of research has demonstrated the 
positive effects of pre-exercise bicarbonate supplementation on pH and lactate levels and 
sports performance.  However, little is known about how herbal supplementation 
influences acid-base balance during vigorous exercise.  The benefits of natural aids 
include legal use in competition along with few side effects, but the ergogenic efficacy is 
less clear.  Some research has shown that supplementation, in the days leading up to an 
exercise trial, increases muscular strength, while others have shown a longer time to 
fatigue.  The present study is designed to examine the potential effects of 21-days of 




physiological parameters (i.e. blood lactate, HR, RER, VE, VO2) with a randomized, 





The objectives of this chapter are to provide an overview of: 1) the relationship 
between blood lactate and blood pH during exercise, 2) the effect of blood pH/lactate 
levels on muscle fatigue, 3) central nervous system fatigue/ interpolated twitch technique, 
4) the effect of blood pH/lactate levels on cycling performance, 5) the effect of blood 
pH/lactate levels on blood flow, 6) the effect of SR2W-1 on exercise performance, 7) and 
the effect of SR2W-1 on blood lactate handling. 
 
The Relationship between Blood Lactate and Blood pH 
Blood lactate and blood pH are two of the most observed physiological 
parameters in exercise research.  Medbo et al. demonstrated that there is linearity 
between blood pH and lactate levels during high intensity exercise, such that as lactate 
increases, and blood pH decreases (39).  The strong relationship between these blood 
parameters has been consistently reproduced so much that it is considered paradigmatic 
within the field of exercise science, as shown in Table 2.1 (25, 39, 42, 54, 59).  As 
explained by Morris & Shafer, anaerobic glycolytic rates parallel exercise intensity (42).  
Mechanistically, as ATP demands escalate, the rate of pyruvate production via glycolysis 
exceeds pyruvate oxidative capacity.  In this environment, much of the produced 
pyruvate is not being oxidized, and is alternately reduced to lactate and disassociated 




Pharmacological strategies to modify blood pH, further illustrates the relationship 
between lactate and pH.  Specifically, in order to prevent marked disruptions in acid-base 
balance, the blood has a bicarbonate (HCO3
-
) blood buffering system.  With any 
reduction in buffering capacity, much like is the case during high intensity exercise, H
+
 
ions accumulate and blood pH declines (17).  By inducing alkalosis through bicarbonate 
ingestion (enhancing blood buffering capacity), McCartney found significantly lower 
lactate levels throughout exercise (38).  These findings are supported some (17, 46), but 
not all (50) comparable studies.  Interestingly, Potteiger et al., demonstrated improved 
performance by inducing alkalosis, but lactate levels were also elevated (46).  The 
authors suggested that the elevated lactate levels are due to the shunt of lactate from 




Table 2.1 Relationship between Blood Lactate and Blood pH 







N=1 (M) 2 experiments- 
• 2days of 15g  
   ammonium  
   chloride 
• 1 day of 10g  
   sodium  
   bicarbonate 
• 7.4kph to fatigue  
   (ammonium  
   chloride) 
• run to fatigue at  
   9.3kph (sodium  
   bicarbonate) 
 
↓ blood buffering 












• blood pH before,  
   during and after  
   exercise 
•  muscle pH via  
   before, during  
   and after exercise 
 
• Short term max  
   exercise, intensity  
   not specified-  
   continuous (2min to  
   exhaustion) 
• intermittent (40-60s  
   work to exhaustion:  
   4 min rest, repeated  
   5 times) 
 
↓ pH w/ both protocols; 





N = 6 (M) Supplements (0.3 
g/kg): 
• CaCO3 (C) 
• NaHCO3 (alk) 
• NH4Cl (acd) 
• 5% CO2 - 21%  
   O2 - 74% N2  
   (RAC) 
 
30s at max on cycle 
ergometer at 100 rpm 
↓ [LA] in acd and RAC 
Usaj & Starc, 
1995 
(59) 






•blood pH/lactate  
   taken post- 
   exercise 
 
2 protocols: 
• 5-8 runs of 1200m at  
   constant pace of 3.4- 
   4.8 m/s (REC) 
• 4.2-5.6m/s (COMP) 
• 8 runs of 2000m at  
   constant pace 
 
pH was better 
parameter for short term 
endurance performance 
than lactate 
M = male, F = female, yo = years old, s = seconds, min = minutes, h = hours, C = control, 
alk = metabolic alkalosis, acd = metabolic acidosis, RAC = respiratory acidosis, ME = 
maximal effort; [LA]= lactate concentration, COMP = competitive, REC = recreational, 




Table 2.1 Relationship between Blood Lactate and Blood pH (continued) 











• 0.5g/kg sodium  
   citrate 





N = 7; trained 
cyclists  
• Venous blood  
   samples: after each 
   bout, pre/post  
   exercise protocol 
• Muscle biopsy:   
   pre/post  
   exercise protocol 
 
8 x 5min cycling at 
86% VO2max 




N = 6 (M), 
REC 
exercisers 
Ingested 1.5h prior to 
trial:  
• NaHCO3 (alk) or 
• placebo (C)  
 
Continuous wrist 
flexion to fatigue in 
supine position 




N = 7 (M) Blood taken at 30s, 
60s, 90s post warm 




• 15min warm up  
   at 50% VO2max 
• ~2min cycle to  
   exhaustion at  
   max VO2max 
 
















 during  
exercise, post-exercise 
 
• Graded submax  
   test to determine  
   PLT, PLT1,  
   PpHT 
• discontinuous  
   exercise test  
   (9min bouts) to  
   determine  
   PMLSS 
• 20km TT to find  
   mean power  
   output 
 
↑ intensity led to ↑ 
reliance on anaerobic 
glycolysis 
M = male, F = female, yo = years old, s = seconds, min = minutes, h = hours, C = control, 
alk = metabolic alkalosis, acd = metabolic acidosis, [LA]= lactate concentration, TT = 
timed trial, PLT = highest power output with no lactate increase from baseline, PLT1 = 
highest power output with no increase in lactate above 1mmol/L, PpHT = highest power 
output with no decrease in pH below baseline, PMLSS = highest power output during a 
9-min steady state with no increase in lactate above 1mmol/LCOMP = competitive, REC 




Effect of Blood pH/Lactate Levels on Muscle Fatigue 
As previously stated, blood pH/lactate levels parallel exercise intensity.  
Generally, when blood pH levels drop and blood lactate/ H
+
 ions accumulate, muscle 
fatigue ensues (55, 63).  Muscle fatigue can be broadly defined as “an exercise-induced 
reduction in maximal voluntary muscle force” (22).  Due to the causal relationship 
between muscle fatigue and exercise performance limitations, it is of interest to further 
explore this relationship by focusing on contributing factors such as blood pH/lactate.   
In an exercise scenario, blood buffering capacity (HCO3) is a prominent 
contributor to muscle fatigue.  A low buffering capacity impairs the blood‟s ability to 
buffer H
+
 ions during high intensity exercise, ultimately impairing exercise performance 
(17).  Along with an accumulation of H
+
 ions, pH declines.  To further display the 
importance of pH and muscle fatigue, Coyle et al. took two groups of cyclists, one group 
with low lactate thresholds and another high lactate thresholds (16).  The authors reported 
that cyclists with higher lactate thresholds were able to ride two times longer than those 
with low lactate thresholds (16).  In retrospect, these results present the importance of 
maintaining low lactate levels, as to delay muscle fatigue and increase the duration of 
performance.  Additional research has displayed similar findings by inducing alkalosis 
and observing changes in skeletal muscle fatigue and exercise performance (17, 26, 60, 
63). 
In addition to the effects of induced alkalosis on general muscle fatigue, studies 
have also examined the effects of alkalosis on neuromuscular physiology.  While in a 
state of induced alkalosis, both nerve/synapse activity and muscle fiber conduction 
velocity were augmented, when in comparison to normal conditions (26, 60).  This 




peripheral fatigue under these conditions (26, 60).  Interestingly, Patterson et al examined 
the composition of sweat during exercise and found that there was a reduction of serum 
K
+
 levels with the ingestion of NaHCO3 (45).  This finding leads to the assumption that 
serum K
+
 levels are better retained with alkalosis, and can be used as a loose reflection of 
blood composition (45).  In application, consistent serum K
+
 levels can be used to 
represent resistance to diminishing contractile properties in the sarcolemma during 
strenuous exercise, with neuromuscular function linked to the degree of conductance 





Table 2.2 Blood pH/Lactate and Muscle Fatigue 






N=1 (M) 2 experiments: 
• 2days of 15g  
   ammonium chloride 
• 1 day of 10g sodium  
   bicarbonate 
 
• 7.4kph to fatigue  
   (ammonium  
   chloride) 
• run to fatigue at  
   9.3kph (sodium  
   bicarbonate) 
 
↓ blood buffering 









N = 14 (M), 
cyclists 
• low LT 
• high LT 
TTE @ 88% (stop 
when < 87%) 
↑ 2x TTE w/ high LT, 
↓ [LA] post- exercise 




N = 6 (M), 
REC 
exercisers 
400mg/kg ingestion of 




• cycling at max 
• 2 supramax (max +  
   17%) tests C & alk,  
   IT pre/post tests 
 
↑ peak and residual 




Mice alk, acd, C @ 12°C, 
22°C, 32°C 





↓ muscle contraction 
w/ ↑ temp and ↓ pH 
Vissing, 1998 
(61) 




MSNA taken, no other 
medications were taken 
 
Static handgrip 
exercise at 30% 
VO2max to exhaustion 
↑ pH and MSNA 
despite ↔ [LA] 
M = male, F = female, s = seconds, min = minutes, h = hours, C = control, alk = 
metabolic alkalosis, MVC = maximal voluntary contraction, TTE = time to exhaustion, 
LT = lactate threshold, IT = interpolated twitch with isometric MVC, MSNA = muscle 
sympathetic nerve activity, TT = timed trial, [LA] = lactate concentration, ↔ = no 







Table 2.2 Blood pH/Lactate and Muscle Fatigue (continued) 











• NaHCO3 (alk)  
• placebo (C) 
•  ingested in 6  
   equal doses over  
   2h, 1h prior to trial 
 
TT for 90min at 
62.5% VO2max, self- 
selected rpm; each 








N = 8 (M) 
distance runners 
• pre/post MVC and  
   LOA  
• no blood  
   parameters 
• running 2h at  
   75% VO2max with  
   1 degree incline 
• IT pre/post run 
 
↓ MVC and LOA 
post-run found 




N = 16 (M) • pre/post fatigue  
   [LA] 










N = 10 (M), 
trained cyclists 
Pre/post-exercise 
muscle function test; 
HR & [LA] 
immediate post-
exercise 
• 33 min cycle @  
   70%  or 
• 20sec high  
   intensity intervals  
   of  200, 150,  
   100% VO2max x 3  
   min rest @ 50%   
   x10 (total of  
   33min)  
 
↓ MVC, % activation, 
pH during intervals 
(peripheral & CNS) 
M = male, F = female, s = seconds, min = minutes, h = hours, ME = max effort, C = 
control, alk = metabolic alkalosis, MVC = maximal voluntary contraction, LOA = level 
of activation, IT = interpolated twitch with isometric MVC, TT = timed trial, [LA] = 






Table 2.2 Blood pH/Lactate and Muscle Fatigue (continued) 










• NaHCO3 (alk) 
• placebo (C) 
• ingested 3h prior  
   to trial 
• 50min of submax  
   cycling 
• 50s sustained  
   isometric  
   contraction 
 
↑ muscle fiber 




N = 15 semi-
professional 
cyclists (5 yr 
experience) 
7 blood draws 
throughout test and 
30s post-exercise 
2 tests: 
• incremental max  
   test at incline of  
   5.84 
• uphill 12min field   
   test 
• 3 knee extensions  
   with dynamometer  










• Blood pre-  
   exercise, 1/3
rd
 ,  
   2/3
rd
 during  
   exercise, post-  
   exercise 
 
• Graded submax  
   test  
   to determine PLT,  
   PLT1, PpHT 
• discontinuous  
   exercise test (9min  
   bouts) to    
   determine  
   PMLSS 
• 20km TT to find  
   mean power  
   output 
 
↔ pH while ↑[LA] 
during TT; lactate not 
attributed to fatigue 
Tenan, 2010 
(57) 
N = 8 (4 M, 4 
F) 
• normal condition 
• glycogen reduced  
   condition 
 
Discontinuous GXT ↓ [LA] in glycogen 
reduced; ↔ fatigue 
M = male, F = female, s = seconds, min = minutes, h = hours, ME = max effort, C = 
control, alk = metabolic alkalosis, TT = time trial, MVC = maximal voluntary 
contraction, LOA = level of activation, IT = interpolated twitch with isometric MVC, 
GXT = graded exercise test, TT = timed trial, [LA] = lactate concentration, ↔ = no 




Central Nervous System Fatigue/Interpolated Twitch Technique  
The factors involved in skeletal muscle fatigue can be put into one of two 
categories: central fatigue or peripheral fatigue.  With respect to central fatigue, 
researchers have examined possible interference in efferent/afferent signaling between 
the central nervous system (CNS) and muscle fibers.   Peripheral factors contributing to 
fatigue include a malfunction in contractile properties within the sarcomere.  Known to 
limit exercise performance, targeting the source of fatigue has become important in 
performance enhancement. 
As a potential limitation to exercise performance, CNS fatigue has been 
extensively researched with the use of muscle function tests.  In addition to the use of 
iEMG readings, the interpolated twitch technique (ITT) assesses the extent of muscle 
activation before and after exercise.  By sending a superimposed twitch through a set of 
surface electrodes placed directly above the targeted muscle during a maximal voluntary 
contraction (MVC), it is assumed that 100% muscle fiber recruitment is achieved.  The 
difference between peak torque and peak torque + superimposed twitch (100% 
recruitment) is used to determine fatigue, by comparison of pre/post-exercise muscle 
function testing.  Although only three of the nine relevant studies (Table 2.3) reported 
greater CNS fatigue than peripheral fatigue, all of the studies found that skeletal muscle 
fatigue results from elements of both peripheral and central fatigue (4, 33, 49, 56).  
According to Kent-Braun, around 20% of fatigue from exercise can be attributed to CNS, 
while the remaining 80% due to peripheral/contractile fatigue (28).  In contrast, 3 of the 9 
studies failed to observe changes in post-exercise CNS function (32, 34, 47).  In support 
of peripheral fatigue being a more sizable factor than CNS function, Presland & Dowson 




leading to the assumption that fatigue was due to peripheral factors (47).  Despite 
equivocal findings over the development of CNS and peripheral fatigue, the origin of 
fatigue may be time and intensity dependant.  Specifically, Lepers et al. found that 
throughout a 5 hour cycling ride at 55% VO2max, peripheral fatigue increased primarily 
throughout the 1
st
 hour, while CNS fatigue played a more prominent role in the later 
stages of the ride (33).  This suggests that fatigue during high intensity exercise may 






Table 2.3 Central Nervous System Fatigue/Interpolated Twitch Technique 











• 3 CNS tests-  
   central activation  
   ratio (peak  
   MVC/peak total  
   force) 
• compare MVC  
   w/ titanic force,  
   compare iEMG  
   signal w/ change  
   in activation  
   potential 
• 1 peripheral test-  
   magnetic   
   resonance  
   spectroscopy 
 
4 minute sustained 
isometric MVC of 
ankle dorsiflexors 
Central factors 20%, 








concentric) via EMG 
& IT 
 
• 30min cycle at  
   80% VO2  
   (freely chosen  
   cadence-FCC) 
• 30min cycle at  
   80% VO2max at  
   FCC+20% 
• 30min cycle at  
   80% VO2max at  
   FCC-20% 
 
↔ CNS fatigue 
between 3 cadences 
Lepers, 2002 
(33) 




ITT before start of 
each hour and 30min 
into recovery 
 
5 hour cycle @ 
55% 
↑ peripheral fatigue in 1 




N = 8 (M) • Blood pH/lactate  
   samples post- 
   exercise 
• pre/post  
   neuromuscular   
   tests 
 
Ten 1min runs @ 
max aerobic 
velocity (18% 
grade) w/ 2min 
rest periods 
↔ CNS fatigue; ↓ 
peripheral fatigue 
M = male, F = female, s = seconds, min = minutes, h = hours, ME = max effort, C = 
control, MAL = metabolic alkalosis, MVC = maximal voluntary contraction, LOA = 
level of activation, IT = interpolated twitch with isometric MVC, CNS = central nervous 






Table 2.3 Central Nervous System Fatigue/Interpolated Twitch Technique 
(continued) 







N = 15 (M), REC Pre/post isometric 
MVC with right 
leg; 3 times w/1min 
rest interval 
 
70% VO2 to 
exhaustion 
↓ MVC by 30%; ↔ 










coupling process of 
knee extensors 
 










N = 9 (M) 
 
• ITT pre/post- 
   exercise 
• muscle  
   oxygenation  
   recorded via near- 
   infrared  
   spectroscopy 
 
Repeated sprints 
10 x 6 seconds @ 
0.9 N/kg w/ 30 
second recovery 
↓ motor drive post-













5km TT w/ 
varying starting % 
of fatigue (0, 67, 
83%) 
 





N = 8 
 
2 groups: 
• placebo (C) 
• 10mg  
   methylphenidate 
 
Cycle @ RPE of 
16 (Borg scale) 
until PO < 70% of 
initial PO 
 
↑ time 32% with 
methylphenidate 
 
M = male, F = female, s = seconds, min = minutes, h = hours, ME = max effort, C = 
control, MAL = metabolic alkalosis, MVC = maximal voluntary contraction, LOA = 
level of activation, IT = interpolated twitch with isometric MVC, CNS = central nervous 






Blood pH/Lactate Levels and Exercise Performance 
 As previously discussed, there is a causal relationship between muscle fatigue and 
exercise performance; therefore it is logical to expect that blood pH and lactate‟s effect 
on muscle function will similarly impact performance.  Many studies have examined this 
potential relationship between the two blood parameters and exercise performance (Table 
2.4 and Table 2.5).  While earlier research explored the general relationship between 
blood lactate/ pH and exercise performance, more recent research has focused on whether 
or not the manipulation of these parameters impact athletic performance.  It is well 
documented that metabolic acidosis and metabolic alkalosis yield divergent performance 
outcomes, such that metabolic acidosis impairs performance and metabolic alkalosis 
improves performance (13, 27, 36, 38, 45, 46, 50, 60).  Further, of these studies, all but a 
few have found significant correlations between higher blood pH/ lower lactate levels and 
improved exercise performance. 
 Research has consistently displayed in the now predictable relationship between 
pH, exercise intensity and exercise duration, with a rise in pH during high exercise 
intensities (25, 42, 54, 59).  As this concept became better established, attempts to 
manipulate pH via sodium bicarbonate (NaHCO3) ingestion became increasingly popular 
in order to study the effects of pH on performance (13, 17, 27, 36, 38, 45, 50, 53, 60).  
Results of these studies seem to consistently show a state of induced alkalosis leading to 
elevated pH levels being maintained throughout exercise and into recovery (17, 45, 46, 
60).  Presumably as a result of elevated pH levels, subjects were able to maintain high 
power outputs, delayed fatigue, and improved time-trial performance (27, 36, 46, 50, 60).  
In contrast, separate investigations reported that ingesting 0.3 g/kg NaHCO3 had no effect 




 Although few in number, the studies that have found a correlation between 
induced alkalosis and lactate levels, have shown dissimilar results.  Raymer et al. found 
that with continuous wrist flexion to fatigue, despite NaHCO3 ingestion 1.5 hours prior to 
the trial, there were neither significant differences in lactate levels, nor exercise 
performance, in comparison to the control group (50).  Jones et al. found that induced 
alkalosis, despite enhancements in performance, resulted in higher lactate levels 
throughout exercise (27).  Without any supplementation, generally lower blood lactate 
corresponds with better performance (16, 42).  In conclusion, as blood pH decreases and 













Table 2.4 Blood pH and Exercise Performance 












• CaCO3 (C) 
• NaHCO3 (alk) 
• NH4Cl(acd); 
• double blind  
   fashion 
• taken 3h  
   preceding trial 
 
3 trials for each 
subject: 
• cycling at 33%  
   (20m) 
• 66% (20m) 
• 95% (to exhaustion) 
↑ endurance time and 
↑power output w/ alk 





N = 6 (M); 
age 19-23 yo 
Supplements (0.3 
g/kg): 
• CaCO3 (C) 
• NaHCO3 (alk) 
• NH4Cl (acd) 
• 5% CO2 - 21%  
   O2 - 74% N2  
   (RAC) 
 
30s ME on cycle 
ergometer at 100 rpm 
 
↓ ME in acd, RAC 
Potteiger, 1996 
(46) 




• placebo (C) 
• 0.5g/kg sodium  
   citrate 
30km cycling TT ↑TT w/ sodium citrate 
Verbitsky, 1997 
(60) 








• cycling at max 
• supramax (max +  
   17%) 
• alk 1h prior to  
   supramax 
 
↑quad torque in alk 
Patterson, 2002 
(45) 





•  NaHCO3 (alk) 
• placebo (C) 
• ingested in 6  
   equal doses over  
   2h (1h prior to  
   trial) 
 
• Cycle for 90min at  
   62.5% VO2max 
• self- selected rpm 
• each condition  
   tested 7 days apart 
↑pH in alk throughout 
exercise compared to C 
M = male, F = female, yo = years old, s = seconds, min = minutes, h = hours, ME = max 
effort, C = control, alk = metabolic alkalosis, acd = metabolic acidosis, RAC = 
respiratory acidosis, TT = timed trial, PLT = highest power output with no lactate 
increase from baseline, PLT1 = highest power output with no increase in lactate above 
1mmol/L, PpHT = highest power output with no decrease in pH below baseline, PMLSS 
= highest power output during a 9-min steady state with no increase in lactate above 





Table 2.4 Blood pH and Exercise Performance (continued) 






N = 6 (M) trained 
cyclists/triathletes 
Supplements (0.3g/kg): 
•  NaHCO3 (alk) 
• placebo (C) 
•  ingested 2h prior to  
   trial 
 
30min cycling at 
77% VO2max 
followed by TT 




N = 6 (M), REC 
exercisers 
Supplements (0.3 g/kg): 
• NaHCO3 (alk) 
• placebo (C) 
• ingested 1.5h prior to  
   trial 
Continuous wrist 








N = 9 VE, VCO2, PO at 
ventilatory threshold 
• blood pH, lactate, PO2  
   taken @ 175 watts-  
   300 watts 
Continuous, 
incremental TTE 
(↑ 25W every 3 
min) @ 80, 100, 
120 rpm 
 
↓ PO w/ ↑ [LA] @ 








• NaHCO3 (alk) 
• placebo (C) 
• ingested 1.5h prior to  
   trial 
  
200m free-style 
swim at ME 




N = 26 (M), 
trained cyclists 
• 3 blood draws (n = 12)  
   @ pre-exercise, 25%   
   of trial, post-exercise  
   for pH, bicarbonate,  
   lactate 
6 sessions: 
• incremental  
   cycle TTE 
• 2 self-paced  
   FAM trials 
• 3 TT (fast,  
   slow and even  
   paced starting  
   strategies) 
 
↓ finish time, ↑ PO 
w/ fast-paced 
starting strategy; ↔ 
pH & [LA] 
Cameron, 2010 
(13) 
N = 25 (M) rugby 
players 
• placebo (C) 
• 0.3 g/kg NaHCO3 
• 25min warm   
   up 
• 9min high  
   intensity sprint  
   test 
↔ 
M = male, F = female, yo = years old, s = seconds, min = minutes, h = hours, ME = max 
effort, C = control, alk = metabolic alkalosis, acd = metabolic acidosis, [LA] = lactate 
concentration, TTE = time to exhaustion, PO = power output, REC = recreational, FAM 





Table 2.5 Blood Lactate and Exercise Performance 












• CaCO3 (C) 
• NaHCO3 (alk) 
• NH4Cl(acd); 
• double blind  
• taken 3h  
   preceding trial 
 
3 trials for each 
subject: 
• cycling at 33%  
   (20m) 
• 66% (20m) 
• 95% (to  
   exhaustion) 
↓ plasma [LA] associated 
with acidosis and shorter 
endurance time; ↑ plasma 
[LA] associated with 




N = 14 (M) • low LT 
• high LT 
TTE @ 88% (stop 
when < 87%) 
↑ 2x TTE w/ high LT, ↓ 










of NaHCO3 (alk) 1h 
prior to trial 
 tests: 
• cycling at max 
• 2 supramax (max  
   + 17%) tests C &  
   alk, IT pre/post  
   tests 
 
↑ peak and residual knee 
torque in alk 
Stepto, 2001 
(54) 
N = 7; 
trained 
cyclists  
• Venous blood   
   samples after  
   each bout and  
   pre/post exercise 
• muscle biopsy  
   pre/post exercise  
   protocol 
 
8 x 5min cycling at 
86% VO2max 
 
↔ blood [LA], ↑ muscle 
[LA], significant 
correlation between 
average blood [LA] during 








• NaHCO3 (alk)  
• placebo (C) 
• ingested 1.5h  
   prior to trial 
 
Continuous wrist 
flexion to fatigue in 
supine position 
alk: ↑ TTE by 12%, ↑ PO 
M = male, F = female, yo = years old, s = seconds, min = minutes, h = hours, ME = max 
effort, C = control, [LA] = lactate concentration, alk = metabolic alkalosis, acd = 
metabolic acidosis, RAC = respiratory acidosis, ME = maximal effort, REC = 
recreational, TTE = time to exhaustion, PO = power output, ↔ = no difference, ↑ = 








Table 2.5 Blood Lactate and Exercise Performance (continued) 











samples taken from 







Training at intensities 3-
6mmol/L [LA] led to poor 










• Blood pre- exercise,  




 during  
   exercise, post-  
   exercise 
 
• Graded submax  
   test to determine  
   PLT, PLT1,  
   PpHT 
• discontinuous  
   exercise test  
   (9min bouts) to  
   determine  
   PMLSS 
• 20km TT to find  
   mean power  
   output 
 
↔ pH while ↑[LA] during 




N = 8 (4 M, 4 
F) 
• normal conditions 
• glycogen reduced  




↓ [LA] in glycogen 
reduced 
M = male, F = female, yo = years old, s = seconds, min = minutes, h = hours, ME = max 
effort, C = control, [LA] = lactate concentration, alk = metabolic alkalosis, acd = 
metabolic acidosis, PLT = highest power output with no lactate increase from baseline, 
PLT1 = highest power output with no increase in lactate above 1mmol/L, PpHT = highest 
power output with no decrease in pH below baseline, PMLSS = highest power output 
during a 9-min steady state with no increase in lactate above 1mmol/L, TT = time trial,  






The Effects of Blood Flow on Blood pH/Lactate Levels 
 In general, blood flow increases along with exercise intensity (12, 44, 48).  With 
an increase in blood flow during exercise, better transportation is provided for lactate 
clearance during heavy exercise.  However, Bangsbo displayed contradicting results with 
a higher blood flow and lower lactate clearance from muscle (8).  Bangsbo et al. explains 
that a shortened mean transit time in the capillary bed that results from high blood flow, 
leads to a sub- optimal amount of time for exchange of lactate from the muscle to 
capillary blood, resulting in higher blood lactate levels (8).  A prominent variable 
effecting blood flow is hydration status, of which Gonzalez et al. found influenced 
velocity of blood flow in a negative manor.  Another variable effecting of blood flow 
during exercise is vein diameter (23).  Venodilation is known to occur in linearity with 
blood flow.  Calbet et al. provided evidence of this in both the subclavian and femoral 
veins with ergometer cycling (12).  During exercise, both venodilation and increased 
blood flow are known mechanisms that aid in lactate clearance from working muscles 





Table 2.6 Effects of Blood Flow on Blood pH/Lactate Levels 






N = 6 (M) • Blood samples  
   at 0,1,3,5,10  
   and recovery 
• blood flow  
   pre/post  
   exercise via  
   thermodilution 
• One legged  
   exercise at high  
   intensity (59±5.3  
   W) for 10min 
• 7 bouts of either  
   high intensity  
   (90W) or low  
   intensity (13W)  
   for 15s 
 
↑ BF led to ↓ lactate transport 
Gonzalez, 1998 
(23) 
N = 7 (M), 
trained 
cyclists 
•leg blood flow  
   measured via  
   infusion  
   thermodilution  
   technique 
•cycle ~61%  
   VO2max to  
   exhaustion while  
   dehydrated 
• 1 week later,  
   cycle ~61%  
   VO2max for same  
   time as first ride  
   hydrated 
 
↑ BF w/ exercise (hydrated), ↓ 
BF with exercise (dehydrated) 
Calbet, 2007 
(12) 




• upright cycle  
   ergometer and  
   arm cycle  
   ergometer for  
   90min at 60/20%  
   VO2max 
    respectively 
• 1 hr rest 
• Lower body  
   cycle  
   to fatigue 
• 30min rest 
• Upper body  
   cycle to fatigue 











1 legged knee 
extensions at 30 
and 60 CPM at 
work loads 10, 20, 
30, 40 watts 
 
↑  arterial BF w/ increased 
workload 
M = male, F = female, s = seconds, min = minutes, h = hours, CPM = contractions per 
minute, BF = blood flow, [LA] = lactate concentration, ↔ = no difference, ↑ = increase, 






Herbal Supplementation/SR2W-1 and Exercise Performance 
 Of the very few studies conducted on herbal supplementation and exercise 
performance, results have been equivocal (1, 3, 5, 6, 14, 19-21, 31, 62).  Specifically, 
SR2W-1 has been shown to increase time to exhaustion in mice and improved cycling 
time trial performance in humans (1, 31).  Of the ingredients in SR2W-1, ginseng has 
been the most extensively studied for possible ergogenic effects; however, results of 
improved performance are inconsistent (5, 6, 18-21, 62).  Only one of the eight studies 
reviewed in Table 2.7 reported improved exercise time to exhaustion (5).  Other studies 
looking at various forms ginseng have implemented quantities of supplementation 
ranging from 200-1200mg/day, and supplementation periods lasting anywhere from 7 
days to 8 weeks, all of which have shown no effect of ginseng on performance (6, 18-21, 
62).  Another ingredient found in SR2W-1, Cordyceps sinesis, has also been a point of 
interest in the pursuit of herbal supplementation‟s effect of exercise performance.  Colson 
et al (14), implemented a 13-day supplementation phase (2,000mg/day) of Cordyceps 
sinesis-rhodiola rosea and was unable to find any significant increases in time to fatigue 
in cycling performance.  Despite contradictory findings, promising research that has 





Table 2.7 Herbal Supplementation/SR2W-1 and Exercise Performance 






N = 6 (M) • 300mg/d  
   ES Maxim for  
   8days 
• Placebo (C) 
• SB 
•First, 3 GXT  
   cycling on 3  
   consecutive days 
•Second, GXT  
   cycling post 8d C 
•Third, GXT   
   cycling post 8d  
   ES 





N = unknown; 
mice 




Mice exercise, then 





N = 28 (20M, 
8F) 
• 200mg of 7%  
   Panax ginseng for  
   3 weeks 
• Placebo (C)  
Graded ergometer 





N = 12 • 950mg/d  of  
   SR2W-1 for 5  
   weeks 
• placebo (C) 
Post 5-week 
supplementation 
period, cycle at LT for 
20min, 12min 
recovery, 60,000 J TT 
 





N = 9 (M), 
cycle trained 
• 1200mg/d  
   leaf of ES for  
   7days 
• Placebo (C) 
•DB, CX, 7d  
   washout 
Cycle 120min at 
~60% VO2max 





N = 19 (F) • 400mg/d Panax  
   ginseng for 8  
   weeks 
• Placebo (C) 
Supramaximal 
Wingate cycling 
protocol followed by a 
controlled recovery 
↔TTE, power output, 
post exercise HR 
recovery 
M = male, F = female, s = seconds, min = minutes, h = hours, d = day, caps = capsules, C 
= control, ES = Eleutheroccocus senticosus, TTE = time to exhaustion, LT = lactate 
threshold, TT = time trial, SB = single blind, DB = double blind, CX = crossover design, 




Table 2.7 Herbal Supplementation/SR2W-1 and Exercise Performance (continued) 










• 2g/d Panax  
   ginseng for 8  
   weeks 
• Placebo (C) 
Intervals of three  
30-s sprint  
cycle x 3min  
recovery 
↔ PO, HR recovery 
Earnest, 2004 
(18) 
N = 17 (M) 
amateur 
cyclists 
Placebo (C)  & 
ginseng (loading 
phase of 4d- 
6caps/d and 
maintenance phase 
of 11d- 3caps/d) 
 
Graded cycling 
ergometer test to 






N = 8 (M) • 13-day  
   supplementation  
   of 2,000mg  
   Cs-Rr 
• Placebo (C) 





N = 19 (M) 
Field hockey 
players 
• 31-day  
   supplementation  
   440mg/d of  
   lingzhi extract  
   (EXP) 
• Placebo (C) 











N = 35 (M) 
untrained 
• Acute  
   supplementation  
   of 1.35g  
   Kaempferia  
   Parviflora, a.k.a.  
   Thai Ginseng  
   (90min  
   prior to exercise) 
• Placebo (C) 
Two tests: 
•intervals of three  
   30-s sprint  
   cycle x 3min  
   recovery 
•submax cycle to  
   fatigue 
↔ 
M = male, F = female, s = seconds, min = minutes, h = hours, d = day, caps = capsules, C 
= control, TTE = time to exhaustion, LT = lactate threshold, PO = power output, Cs-Rr = 




Herbal Supplementation/SR2W-1 and Blood Lactate Handling 
Very little research has been conducted on the impact of herbal supplementation‟s 
influence on blood lactate production and/or clearance during exercise.  Three of six 
relevant studies (Table 2.8) reported that herbal supplementation reduces blood lactate 
levels during recovery from exercise, compared to the control, one specifically pertaining 
to SR2W-1 (31, 43, 64).  Wu et al. was able to provide evidence that reduction in lactate 
levels during recovery from exercise were actually accelerated with 800mg/day of leaf of 
Eleutheroccocus senticosus (a form of the extract found in SR2W-1) for 14 days (64).  
With 950mg/day of SR2W-1 for 5 weeks, lower lactic acid levels were also accompanied 
by faster subsequent time trial performance (31).  Conversely, Morrissey et al. found that 
with the ingestion of 1000mg of SR2W-1, a reduction in blood lactate levels due to better 
lactate clearance were apparent following two weeks of ingestion, and even more so with 
an additional two additional weeks supplementation (43).  However, others have failed to 
observe changes in any blood parameter or performance with the ingestion of herbal 
ginseng supplementation (3, 18).  Mixed results could be a result of the length and type of 
supplementation.  As provided in Table 2.8, three of the six studies with a longer 




Table 2.8 Herbal Supplement/SR2W-1 and Blood Lactate Handling 






N = 8 (M) • 800mg/d  
   leaf of (ES) for  
   14days 
• Placebo (C) 
Submaximal cycling 
test 
↑↑ reduction in HR and 






N = 30 (M) 3 groups: 
• placebo (C) 
• 500mg SR2W-1 
• 1000mg SR2W-1 
 
Computerized treadmill, 
increasing level of 
difficulty 
↓ [LA] w/ 1000mg 
group (better lactate 
clearance) after 2 week 
supplementation and 





N = 12 • 950mg/d  of  
   SR2W-1 for 5  
   weeks 
• placebo (C) 
 
Cycle 20min at LT ↓[lactic acid] and 
change in pH during 
recovery w/ SR2W-1 
Allen, 1998 
(3) 
N = 28 (20M, 
8F) 
• placebo (C) 
• 200mg of 7%  
   Panax ginseng  
   for 3 weeks 
Graded ergometer 






N = 9 (M), 
cycle trained 
• 1200mg/d  
   leaf of ES for  
   7days 
• Placebo (C) 
•DB, CX, 7d  
   washout 
Cycle 120min at ~60% 





N = 17 (M) 
amateur 
cyclists 
• placebo (C) 
• experimental 14d  
   supplementation  
   period (loading  
   phase of 4d-  
   6caps/d and  
   maintenance  
   phase of 11d-  
   3caps/d) 
 
Graded cycling 




M = male, F = female, s = seconds, min = minutes, h = hours, C = control, DB = double 
blind, CX = crossover design, TT = time trial, TTE = time to exhaustion, LT = lactate 
threshold, [LA] = lactate concentration, ES = Eleutheroccocus senticosus, ↔ = no 





There is an eminently strong relationship between blood pH and lactate, 
especially during exercise.  As exercise intensity increases, blood pH decreases and 
lactate increases (i.e. metabolic acidosis).  When metabolic acidosis occurs, muscle 
fatigue is induced, thereby limiting exercise performance.  Due to positive findings of the 
herbal supplement SR2W-1 on blood lactate levels, and its subsequent influence on 
exercise performance and muscle fatigue, the current study is designed to examine the 
influence of SR2W-1 on blood pH/lactate levels, cycling performance, and central versus 
peripheral fatigue.  Whether central or peripheral fatigue is responsible for decrements 
during intense exercise, performance remains uncertain.  Regardless, lactate and pH has 
been shown to have an effect on muscle fatigue.  Thus, due to the potential effects of 
SR2W-1 on lactate handling and muscle fatigue, supplementation may have an ergogenic 





Ten male and female recreational cyclists, aged 18-55 were recruited from James 
Madison University and the surrounding Harrisonburg area.  Data collection on five 
subjects was delayed due to sickness and scheduling conflicts.  Statistical analysis was 
therefore performed on the remaining five subjects.  Subject characteristics are 
summarized in Table 3.1.  Participants were provided with written and oral information 
about the experimental procedures, including potential risks, prior to informed consent 
(Appendix II).  Prior to testing, all procedures were approved by the James Madison 
University International Review Board. 
 
Table 3.1 Subject Characteristics 
  Age (yrs) Height (cm) Weight (kg) VO2 max (mL/kg/min) 




Cardiorespiratory Fitness (VO2max) 
 Subjects performed a graded exercise test to determine peak oxygen uptake 
(VO2max) on a cycle ergometer (Velotron, Racermate, Inc., Seattle, WA).  The initial 
exercise intensity was subjectively determined during a self-selected 5-minute warm-up.   




to moderate intensity.”  Workload was then uniformly increased by 20 W every 3 
minutes until volitional fatigue or until subjects were unable to maintain a pedaling 
cadence of ≥ 50 revolutions per minute.   VO2, VCO2, RER, and ventilation were 
continuously monitored with a SensorMedics Spectra (Yorba Linda, CA) metabolic cart.  
A Polar (Lake Success, NY) heart rate monitor was used to determine heart rate during 
each test. Blood lactate levels were assessed in the final minute of each exercise stage 
with a blood lactate analyzer (YSI 2300 STAT glucose/lactate analyzer, Yellow Springs, 
Ohio), and used to determine lactate threshold (1 mmol above resting).  RPE was also 
obtained in the final minute of each exercise stage.  Peak power output was used to 
determine workloads during the exercise trials. 
 
Exercise Trials 
Each subject performed a total of five trials over the course of nine weeks.  The 
initial trial served as a familiarization trial, while the remaining four trials were treatment 
trials (TT).  The general study design is shown in Figure 3.1.  The four treatment trials 
were conducted in a randomized, double-blind, crossover design, with the two 
supplementation phases separated by a 14-day washout period.  The first two treatment 
trials were conducted before and after three weeks of supplementation with either placebo 
or SR2W-1.  Following the subsequent washout phase, subjects completed the final two 
treatment trials, which were again conducted before and after three weeks of 
supplementation (opposite treatment- placebo or SR2W-1).  All trials were performed at 
ambient temperatures of 21-22°C.  A Home Essentials fan, set on „medium‟ speed, was 
placed 2 meters from the handlebars of the ergometer for cooling purposes during the 











TT = treatment trial 
 
 A summary of the exercise trial protocol is displayed in Figure 3.2.  Subjects 
reported to the lab after a 10-12 hour fast overnight fast.  To standardize postural-related 
hemodynamics, subjects sat for five minutes prior to blood flow measurements.  Resting 
blood flow of the left femoral artery was then measured via ultrasonography (Mindray 
DC-6, Shenzen, Nanshan, China).  Immediately following blood flow assessment and a 
five minute walking warm up (3.0 mph), pre-exercise muscle function was assessed via 
interpolated twitch, as described below.  This protocol was utilized to obtain isometric 
peak torque (MVC) and percent muscle activation of the right leg extensors. 
 
Figure 3.2 Treatment Trial Design 
 
 
21-Day Supplementation Period 1 14-Day 
Washout 
        TT                       TT               TT                                  TT 




 Following initial skeletal muscle function testing, subjects performed a 3-min 
warm-up at 100 watts, after which wattage was increased to a level that corresponded to 
85% of the subject‟s VO2max (average ± SE = 191 ± 22.2 Watts) and maintained for 20-
minutes.  Immediately following the 20-min phase, subjects completed three one-minute 
intervals at 100% of the power output obtained at VO2max (average ±SE = 276 ± 31.7 
Watts), with 30-seconds of active recovery (100 Watts) between each interval.  Following 
the completion of the final interval, subjects terminated cycling and began a 15-min 
recovery phase during which a series of skeletal muscle function assessments were 
conducted.  Subjects then cycled at a power output that corresponded to VO2max, until 




Cycling duration (seconds) during the time to fatigue portion of the treatment trial 
was used as the performance measure.   
 
Skeletal Muscle Function/Central Nervous System Fatigue 
Prior to each treatment trial, subjects were positioned in a custom-built leg 
extension chair and prepared for electrical stimulation of the right knee extensor muscles.    
Brief electrical stimulations (i.e., paired pulses, consisting of two 0.2-ms pulses with an 
inter-pulse interval of 10 ms) were provided to a relaxed right knee extensor.   The 
stimulator current was set at 90 mA for the first contraction, and progressively increased 




extensors has plateaued (i.e. no further increase in force production).  The current that 
produced the greatest torque within the plateau was used as the supramaximal stimulation 
current for all subsequent stimulations throughout the rest of the study. 
Once the supramaximal current was identified, subjects completed an interpolated 
twitch electrical-stimulation procedure that enabled determination of peak electrically 
evoked isometric torque of the knee extensors (MVC), peak electrically evoked isometric 
torque, and the percent muscle activation during the MVC.  Subjects performed the 
„interpolated twitch‟ procedure prior to each treatment trial, and at minutes 1 and 10 of 
the 15-minute recovery period.   For each interpolated twitch trial, subjects performed a 
3-sec isometric maximum voluntary contraction (MVC) of the knee extensor muscles; at 
2.5 seconds into the contraction, paired-pulse electrical stimulation was delivered to the 
knee extensors to determine interpolated twitch torque (ITT).  Two and four seconds 
following the 3-sec MVC, another paired-pulse stimulation was administered to the 
relaxed muscle to determine the peak electrically-evoked torque (EET).  The percent 
muscle activation (%ACT) was estimated as 100% x (1 – ITT/EET).   This procedure is 
an index of central nervous system fatigue. 
    
Blood Lactate and Glucose 
 At the beginning of each trial, an indwelling antecubital venous catheter was 
inserted.  After insertion, the catheter was flushed periodically with an injectable saline 
solution to keep the catheter patent.   A total of 10 blood samples were obtained at the 
following time-points: 20 minute fixed intensity ride –10 and 20 minutes; intervals – 
immediately following the second 1-minute interval; recovery – 1.5, 3, 6, 9, 12, and 15 




concentrations were assessed immediately following each sample (YSI 2300 STAT 
glucose/lactate analyzer, Yellow Springs, Ohio).   Recovery lactate was reported as area 
underneath the curve during the 15-min recovery period, and compared between 
treatments. 
 
VO2, RER, and Ventilation 
VO2, RER and VE were assessed at minutes 10 and 20 of the fixed-intensity ride 
and at the completion of the second interval of one-minute high-intensity intervals.  A 
SensorMedics Spectra (Yorba Linda, CA) metabolic cart was used to assess breath-by-
breath gas exchange and averaged over one-minute.  The two minutes leading up to the 
desired time points during the 20-min steady state ride (minutes 10 and 20) were 
averaged to represent a mean for oxygen uptake (VO2), expired ventilation (VE), and 
respiratory exchange ratio (RER; indicates relative contributions of fat and carbohydrate 
oxidation to total energy expenditure) at that time.  Thirty seconds prior to the second 




Heart rate was recorded minutes 10 and 20 of the fixed-intensity ride, at the end 
of the second 1-minute interval, and 12-minutes into the recovery period, using a Polar 





Ratings of Perceived Exertion (RPE)  
Subjective ratings of exertion were obtained by having subjects point to a 
corresponding level of exertion on a Borg RPE scale (rated numerically from 6-20).   
RPE was assessed at minutes 10 and 20 of the fixed-intensity ride and at the end of the 
second one-minute interval.   
 
Blood Flow 
Left femoral artery diameter and velocity of blood was assessed via 
ultrasonography (Mindray DC-6 Shenzen, Nanshan, China).  Blood flow (BF) was 
calculated with the following equation: BF = π r
2
 * (blood velocity) * 60s.  Pre-exercise 




Subjects were randomly assigned to receive either 1000 mg of SR2W-1 or 1000 
mg/day of Placebo.   Subjects consumed 2 x 500 mg capsules every morning for 21 days. 
To promote supplementation compliance, subjects were required to text, e-mail, or call a 
specified member of the investigative team at the time of supplementation.  SR2W-1 is a 
proprietary blend of herbs and fungi (primary ingredients: Enoki Mushroom, Eluthero 
Extract, Reishi Mushroom, Tangerine Extract, Cordyceps Mushroom, and Asian 
Ginseng). The placebo was provided by Radix BioResearch and was in capsule form 





Dietary and Exercise Controls 
Subjects were instructed to: 1) Maintain consistent dietary habits for 72 hrs prior 
to each trial, 2) Complete a diet record (Appendix V) for the 24 hrs preceding each trial, 
3) Avoid heavy exercise for 48 hrs prior to each trial, 4) Maintain consistent physical 
activity habits starting 72 hrs prior to the first treatment trial until the completion of the 
final treatment trial (~55 days), and 5) Record all physical activity performed during the 
72 hrs preceding each trial (Appendix VI).  Subjects consumed their final „self-selected‟ 
meal no less than 10 hrs prior to the start of the treatment trials (i.e. dinner on the evening 
prior to testing).   After this time, subjects consumed only water ad libitum until the end 
of each treatment trial (a total of ~10 to 12 hrs of fasting with ad libitum water intake). 
 
Statistical Analyses 
Due to the small sample size used in this study, Wilcoxon Signed-Rank Tests 
were used to compare change-scores, for each dependent variable, from pre- to post- 
supplementation under both EXP and PLA conditions.  Specifically, differences between 
pre- and post-supplementation cycling time to fatigue, MVC, percent muscle activation, 
blood flow, blood glucose, blood lactate, VO2, RER, VE, HR and RPE was compared 
between treatments at a given time point during the exercise trials.  Significance was set 
at p < 0.05, whereas p-values of < 0.1 were categorized as “approaching significance.”  
All recovery blood lactate data is represented as areas underneath the curve.  Results are 
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Purpose: The purpose of this investigation was to examine the potential effects of 
SR2W-1 supplementation on cycling performance, central fatigue, and a variety of 
physiological parameters, including blood lactate, blood pH, heart rate (HR), rating of 
perceived exertion (RPE), oxygen consumption (VO2), expired ventilation (VE), and 
respiratory exchange ratio (RER). Methods: Five recreational cyclists (38 ± 8 yr, 168.4 ± 
4.3 cm, 68.8 ± 5.6 kg, and 54.4 ± 2.6 mL/kg/min) performed 20-min of steady-state 
cycling (~85% VO2max) followed by three 1-min high intensity intervals at VO2max with 
30-sec active recovery periods at 100 W, 15-min passive recovery period, and a ride to 
fatigue (or < 50 RPM) at VO2max.  Subjects were randomly assigned to receive either 
1000mg/d of SR2W-1 (EXP) or 1000mg/d placebo (PLA).  The supplement was 
distributed in a double-blind, crossover fashion.  The twenty-one day supplementation 
periods were separated by a 14-day “washout” period.  Change-scores from pre- to post- 
supplementation were calculated for all parameters, under both PLA and EXP conditions.  
Wilcoxon Signed-Rank Tests were utilized to compare change-scores between PLA and 
EXP conditions. Results: There were no differences between PLA and EXP for any of 
the dependent variables; however several variables approached significance (p < 0.1).  
Specifically blood glucose levels, HR and ventilation increased to a greater extent with 
EXP, compared to PLA throughout the 20-min ride and high intensity intervals. 
Conclusion: Notwithstanding the small sample size, 3 weeks of herbal supplementation 
(SR2W-1) does not appear to aid in cycling performance, attenuate skeletal muscle 











An abundance of exercise science research has focused on the manipulation of 
certain variables to optimize performance.  High intensity endurance performance (i.e. 
cycling and running) is naturally limited by factors that contribute to skeletal muscle 
fatigue.  In 1954, Merton proposed that fatigue results from inconsistent and inadequate 
blood supply to working muscle (40).  The potential role of blood in the development of 
muscle fatigue is not limited to Merton‟s hypothesis but also includes exercise-induced 
variations in the concentration of certain blood parameters, namely hydrogen ions (pH) 
and lactate (22, 25, 27, 38, 40, 42). 
Hermansen and Osnes were among the first to demonstrate the inverse 
relationship between pH (increase in hydrogen ion concentration) and exercise intensity 
(25).  When ATP demands become increasingly high, in accordance with exercise 
intensity, glycolysis generates pyruvate at rates that exceed pyruvate oxidative capacity.  
In this scenario, accumulating amounts of pyruvate are converted into lactic acid, which 
then disassociate into lactate and H
+
 ions (i.e. metabolic acidosis) (10, 51).  Despite these 
events, it has been suggested that proton accumulation during high intensity exercise 
results from ATP hydrolysis, not lactic acid formation (9, 10, 51, 59).  Although still 
unsettled, a powerful model in favor of lactate-induced acidosis includes research on 
individuals with McArdle‟s disease, a disease characterized by the inability to metabolize 
muscle glycogen.  During strenuous activity, McArdle‟s patients are unable to produce 
lactic acid nor experience metabolic acidosis during high intensity physical activity (61). 
 Regardless of the derivation of the hydrogen ions, there is a clear directional 
relationship between exercise intensity, blood pH, and skeletal muscle function.  The 




manipulations of pH facilitated by the ingestion of ammonium chloride (NH4Cl) or 
sodium bicarbonate (NaHCO3), as the two treatments have opposite effects of blood pH 
buffering.  Skeletal muscle power output was impacted by both conditions.  Specifically, 
NaHCO3 ingestion enhanced muscle power output (increased pH), whereas NH4Cl 
impaired power output (decreased pH) (27).  Raymer et al. found that slight alterations in 
blood pH by inducing alkalosis led to a longer time to exhaustion during progressive 
wrist flexions to fatigue (50).  Lindh and colleagues reported significantly faster 
swimming time-trials for the 200-m freestyle with acute ingestion of sodium bicarbonate 
(200 mg/kg of body weight) 60-90 minutes prior to performance (36).  Denning et al. 
concluded that any decrement in HCO3 in the blood led to an impaired ability to buffer 
H
+
 ions during high intensity exercise (leading to acidosis and muscle fatigue) (17). 
While the general relationship between skeletal muscle performance and pH are 
clear (28), underlying mechanisms for this remain uncertain (52, 54).  In addition to the 
aforementioned peripheral factors that are known to inhibit muscle function, fatigue has 
also been correlated with neuromuscular dynamics (26).  Reductions in muscle fiber 
conduction velocity and motor drive have been linked to central nervous system fatigue 
(CNS) (45, 49).   Specifically, Racinais et al. was able to display a decrement in motor 
drive after repeated bouts of interval sprints, in addition to peripheral fatigue (49).  
However, in a state of induced alkalosis, both nerve/synapse activity and muscle fiber 
conduction velocity were augmented, when compared to normal conditions (26, 60).  
This finding suggests that fatigue is, to a greater extent, attributable to CNS fatigue rather 
than peripheral fatigue under these conditions (26, 60).  Specifically, elevated serum K
+
 




preserving contractile properties in the sarcolemma (i.e. attenuation of central fatigue) 
(45).  Additionally, muscle fiber conduction velocity is sustained throughout prolonged 
submaximal cycling in a state of alkalosis, thus maintaining greater resistance to fatigue 
(26).  Kent-Braun demonstrated that there is a strong non-linear association between pH 
and force (r = 0.95), 20% of which is attributable to central fatigue, with the remaining 
attributed to peripheral fatigue (28).  However, it remains unclear whether central or 
peripheral fatigue is most effected by induced alkalosis, and if duration or intensity of 
exercise dictate the source of fatigue that is effected (52, 54). 
Recent research has been conducted on the possible ergogenic effects of herbal 
supplements that are in line with NCAA and IOC regulations and associated with 
minimal side effects.  As explained by L.R. Kleijnen et al., ergogenic herbs are classified 
as adaptogens, which reportedly relieves central nervous system stress rather than 
providing a stimulatory effect, much like other ergogenic aids (30).  However, if taken in 
excess, herbal supplements may cause hypertension, irritability, insomnia and 
gastrointestinal distress (37).  Although the data is equivocal on the effects of herbal aids, 
some studies have demonstrated gains in muscular strength, maximal oxygen uptake, and 
lactate handling (11, 18, 31).  Various forms of ginseng and mushroom have been some 
of the more popular forms of herbal supplementation that have been researched, both of 
which can be found in commercially available SR2W-1 (11).  These key ingredients have 
been shown to aid in lactate maintenance and exercise performance (1, 5, 31, 64).  A 
limited amount of research has demonstrated positive ergogenic effects specific to 
SR2W-1 supplementation in both humans and mice (1, 31).  Although it is still unclear as 




be the key to exposing factors involved with muscle fatigue.  Therefore, primary aim of 
this study was to examine the potential effects of 21-days of SR2W-1 supplementation on 
cycling performance, muscle fatigue, and various other physiological parameters (i.e. 







Ten male and female recreational cyclists, aged 18-55 were recruited from James 
Madison University and the surrounding Harrisonburg area.  Data collection on five 
subjects was delayed due to sickness and scheduling conflicts.  Statistical analysis was 
therefore performed on the remaining five subjects.  Subject characteristics are 
summarized in Table 4.1.  Participants were provided with written and oral information 
about the experimental procedures, including potential risks, prior to informed consent 
(Appendix II).  Prior to testing, all procedures were approved by the James Madison 
University International Review Board. 
 
Table 4.1 Subject Characteristics 
  Age (yrs) Height (cm) Weight (kg) VO2 max (mL/kg/min) 




Cardiorespiratory Fitness (VO2max) 
 Subjects performed a graded exercise test to determine peak oxygen uptake 
(VO2max) on a cycle ergometer (Velotron, Racermate, Inc., Seattle, WA).  The initial 
exercise intensity was subjectively determined during a self-selected 5-minute warm-up.   
Subjects selected an intensity that could be maintained during a prolonged ride of “easy 
to moderate intensity.”  Workload was then uniformly increased by 20 W every 3 




cadence of ≥ 50 revolutions per minute.   VO2, VCO2, RER, and ventilation were 
continuously monitored with a SensorMedics Spectra (Yorba Linda, CA) metabolic cart.  
A Polar (Lake Success, NY) heart rate monitor was used to determine heart rate during 
each test. Blood lactate levels were assessed in the final minute of each exercise stage 
with a blood lactate analyzer (YSI 2300 STAT glucose/lactate analyzer, Yellow Springs, 
Ohio), and used to determine lactate threshold (1 mmol above resting).  RPE was also 
obtained in the final minute of each exercise stage.  Peak power output was used to 
determine workloads during the exercise trials. 
 
Exercise Trials 
Each subject performed a total of five trials over the course of nine weeks.  The 
initial trial served as a familiarization trial, while the remaining four trials were treatment 
trials (TT).  The general study design is shown in Figure 4.1.  The four treatment trials 
were conducted in a randomized, double-blind, crossover design, with the two 
supplementation phases separated by a 14-day washout period.  The first two treatment 
trials were conducted before and after three weeks of supplementation with either placebo 
or SR2W-1.  Following the subsequent washout phase, subjects completed the final two 
treatment trials, which were again conducted before and after three weeks of 
supplementation (opposite treatment- placebo or SR2W-1).  All trials were performed at 
ambient temperatures of 21-22°C.  A Home Essentials fan, set on „medium‟ speed, was 
placed 2 meters from the handlebars of the ergometer for cooling purposes during the 










TT = treatment trial 
 A summary of the exercise trial protocol is displayed in Figure 4.2.  Subjects 
reported to the lab after a 10-12 hour fast overnight fast.  To standardize postural-related 
hemodynamics, subjects sat for five minutes prior to blood flow measurements.  Resting 
blood flow of the left femoral artery was then measured via ultrasonography (Mindray 
DC-6, Shenzen, Nanshan, China).  Immediately following blood flow assessment and a 
five minute walking warm up (3.0 mph), pre-exercise muscle function was assessed via 
interpolated twitch, as described below.  This protocol was utilized to obtain isometric 
peak torque (MVC) and percent muscle activation of the right leg extensors. 
 
Figure 4.2 Treatment Trial Design 
 
 
21-Day Supplementation Period 1 14-Day 
Washout 
        TT                        TT        TT                                     TT 




 Following initial skeletal muscle function testing, subjects performed a 3-min 
warm-up at 100 watts, after which wattage was increased to a level that corresponded to 
85% of the subject‟s VO2max (average ±SE = 191 ± 22.2 watts) and maintained for 20-
minutes.  Immediately following the 20-min phase, subjects completed three one-minute 
intervals at 100% of the power output obtained at VO2max (average ±SE = 276 ± 32 
watts), with 30-seconds of active recovery (100 Watts) between each interval.  Following 
the completion of the final interval, subjects terminated cycling and began a 15-min 
recovery phase during which a series of skeletal muscle function assessments were 
conducted.  Subjects then cycled at a power output that corresponded to VO2max until 





Cycling duration (seconds) during the time to fatigue portion of the treatment trial 
was used as the performance measure. 
 
Skeletal Muscle Function/Central Nervous System Fatigue 
Prior to each treatment trial, subjects were positioned in a custom-built leg 
extension chair and prepared for electrical stimulation of the right knee extensor muscles.    
Brief electrical stimulations (i.e., paired pulses, consisting of two 0.2-ms pulses with an 
inter-pulse interval of 10 ms) were provided to a relaxed right knee extensor.   The 
stimulator current was set at 90 mA for the first contraction, and progressively increased 




extensors has plateaued (i.e. no further increase in force production).  The current that 
produced the greatest torque within the plateau was used as the supramaximal stimulation 
current for all subsequent stimulations throughout the rest of the study. 
Once the supramaximal current was identified, subjects completed an interpolated 
twitch electrical-stimulation procedure that enabled determination of peak electrically 
evoked isometric torque of the knee extensors (MVC), peak electrically evoked isometric 
torque, and the percent muscle activation during the MVC.  Subjects performed the 
„interpolated twitch‟ procedure prior to each treatment trial, and at minutes 1 and 10 of 
the 15-minute recovery period.   For each interpolated twitch trial, subjects performed a 
3-sec isometric maximum voluntary contraction (MVC) of the knee extensor muscles; at 
2.5 seconds into the contraction, paired-pulse electrical stimulation was delivered to the 
knee extensors to determine interpolated twitch torque (ITT).  Two and four seconds 
following the 3-sec MVC, another paired-pulse stimulation was administered to the 
relaxed muscle to determine the peak electrically evoked torque (EET).  The percent 
muscle activation (%ACT) was estimated as 100% x (1 – ITT/EET).   This procedure was 
utilized as an index of central nervous system fatigue. 
   
Blood Lactate and Glucose 
 At the beginning of each trial, an indwelling antecubital venous catheter was 
inserted.  After insertion, the catheter was flushed periodically with an injectable saline 
solution to keep the catheter patent.   A total of 15 blood samples were obtained at the 
following time-points: 20 minute fixed intensity ride – 10 and 20 minutes; intervals – 
immediately following the first 1-minute interval; recovery – 1.5, 3, 6, 9, 12, and 15 




concentrations were assessed immediately following each sample (YSI 2300 STAT 
glucose/lactate analyzer, Yellow Springs, Ohio).   Recovery lactate was reported as area 
underneath the curve during the 15-min recovery period, and compared between 
treatments. 
 
VO2, RER, and Ventilation 
VO2, RER and VE were assessed at minutes 10 and 20 of the fixed-intensity ride 
and at the completion of the second interval of one-minute intervals.  A SensorMedics 
Spectra (Yorba Linda, CA) metabolic cart was used to assess breath-by-breath gas 
exchange and averaged over one-minute.  The two minutes leading up to the desired time 
points during the 20-min steady state ride (minutes 10 and 20) were averaged to represent 
a mean for oxygen uptake (VO2), expired ventilation (VE), and respiratory exchange 
ratio (RER; indicates relative contributions of fat and carbohydrate oxidation to total 
energy expenditure) at that time.  Thirty seconds prior to the second completion of the 
second one-minute interval, VO2, VE and RER were assessed a final time. 
 
Heart Rate 
Heart rate was recorded at minutes 10 and 20 of the fixed-intensity ride, at the end 
of the second 1-minute interval, and 12-minutes into the recovery period, using a Polar 







Ratings of Perceived Exertion (RPE)  
Subjective ratings of exertion were obtained by having subjects point to a 
corresponding level of exertion on a Borg RPE scale (rated numerically from 6-20).   
RPE was assessed at minutes 10 and 20 of the fixed-intensity ride and at the end of the 
second one-minute interval.   
 
Blood Flow 
Left femoral artery diameter and velocity of blood was assessed via 
ultrasonography (Mindray DC-6 Shenzen, Nanshan, China).  Blood flow (BF) was 
calculated with the following equation: BF = π r
2
 * (blood velocity(cm/s)) * 60s.  Pre-




Subjects were randomly assigned to receive either 1000 mg of SR2W-1 or 1000 
mg/day of Placebo.   Subjects consumed 2 x 500 mg capsules every morning for 21 days. 
To promote supplementation compliance, subjects were required to text, e-mail, or call a 
specified member of the investigative team at the time of supplementation. SR2W-1 is a 
proprietary blend of herbs and fungi (primary ingredients: Enoki Mushroom, Eluthero 
Extract, Reishi Mushroom, Tangerine Extract, Cordyceps Mushroom, and Asian 
Ginseng). The placebo was provided by Radix BioResearch and was in capsule form 





Dietary and Exercise Controls 
Subjects were instructed to: 1) Maintain consistent dietary habits for 72 hrs prior 
to each trial, 2) Complete a diet record (Appendix V) for the 24 hrs preceding each trial, 
3) Avoid heavy exercise for 48 hrs prior to each trial, 4) Maintain consistent physical 
activity habits starting 72 hrs prior to the first treatment trial until the completion of the 
final treatment trial (~55 days), and 5) Record all physical activity performed during the 
72 hrs preceding each trial (Appendix VI).  Subjects consumed their final „self-selected‟ 
meal no less than 10 hrs prior to the start of the treatment trials (i.e. dinner on the evening 
prior to testing).   After this time, subjects consumed only water ad libitum until the end 
of each treatment trial (a total of ~10 to 12 hrs of fasting with ad libitum water intake). 
 
Statistical Analyses 
Due to the small sample size used in this study, Wilcoxon Signed-Rank Tests 
were used to compare change-scores, for each dependent variable, from pre- to post- 
supplementation under both EXP and PLA conditions.  Specifically, differences between 
pre- and post-supplementation cycling time to fatigue, MVC, percent muscle activation, 
blood flow, blood glucose, blood lactate, VO2, RER, VE, HR and RPE were compared 
between treatments at a given time point during the exercise trials.  Significance was set 
at p < 0.05, whereas p-values of < 0.1 were categorized as “approaching significance.”  
All recovery blood lactate data is represented as areas underneath the curve.  Results are 






Changes in time to fatigue, before and after 21 days of supplementation were not 
different between PLA and EXP.  Individual performance times are displayed in Figure 
4.3 (pre-PLA: 131.0 ± 15.4 sec; post PLA: 134.0 ± 16.2; pre-EXP: 130.0 ± 8.1; post-






































Skeletal Muscle Function/ Central Nervous System Fatigue 
Changes in MVC and muscle activation resulting from exercise, before and after 
21 days of supplementation were not different between PLA and EXP (Table 4.2).  
Average MVC data are displayed in Figure 4.4.  Average percent muscle activation, pre- 
to post-supplementation, are displayed in Figure 4.5. 
 
Table 4.2 Decline in Muscle Function and Activation with Exercise 
 PLA EXP 
 
Pre Ex to 1-min 
Post Ex 
Pre Ex to 10-min 
Post Ex 
Pre Ex to 1-min 
Post Ex 




Decline in Force 
(N) 
71.2 ± 32.2 46.7 ± 21.0 67.0 ± 30.0 25.1 ± 11.2 
Post 
Supplementation 
Decline in Force 
(N) 












-3.2 ± -1.4 -4.3 ± -1.9 -2.3 ± -1.0 0.6 ± 0.3 
 






























pre exercise 1-min post exercise 10-min post exercise
 
 * p < 0.05 compared to pre-exercise MVC 
  * 




















































Blood Lactate and Glucose 
Changes in blood glucose and blood lactate, before and after 21 days of 
supplementation were not different between PLA and EXP, with the exception of minute 
10.  Average blood glucose and lactate levels are displayed in Table 4.3. 
 
Table 4.3 Blood Glucose and Lactate Levels Before and Following Supplementation 
  Placebo Experimental 




 (mmol/L) 83.4 ± 2.9 83.0 ± 2.5 81.1 ± 1.7 85.3 ± 1.6 
Lactate* (mg/dL) 4.4 ± 0.8 3.9 ± 0.7 4.3 ± 0.5 4.6 ± 0.6 
20 
Glucose (mmol/L) 95.7 ± 5.6 92.2 ± 4.0 94.3 ± 4.9 98.3 ± 3.7 
Lactate (mg/dL) 5.9 ± 1.1 5.0 ± 0.9 5.7 ± 1.0 5.6 ± 1.0 
22:30 
Glucose (mmol/L) 100.9 ± 5.7 96.9 ± 4.5 97.6 ± 5.7 102.0 ± 83.5 
Lactate (mg/dL) 7.4 ± 1.0 6.5 ± 0.9 7.1 ± 1.0 6.7 ± 0.8 
15-min 
recovery AUC 
Lactate (mg/dL) 88.2 ± 13.6 76.5 ± 10.2 83.2 ± 13.7 77.6 ± 9.7 
* p < 0.05 compared to EXP; 
†












VO2, RER, Ventilation 
Changes in VO2 (L/min and mL/kg/min), RER, and VE (L/min) before and after 
21 days of supplementation were not different between PLA and EXP, except for VE at 
minute 10.  Average VO2, RER, and VE are displayed in Table 4.4.   
 
Table 4.4 VO2, RER, VE Before and Following Supplementation 
  Placebo Experimental 
Time (min) Variable Pre Post Pre Post 
10 
VO2 (L/min) † 3.3 ± 0.3 3.03 ± 0.3 3.1 ± 0.3 3.3 ± 0.3 
VO2 (L/kg/min) 47.9 ± 1.5 44 ± 2.7 46.5 ± 2.9 47.0 ± 1.8 
RER 0.94 ± 0.02 0.93 ± 0.03 0.93 ± 0.03 0.92 ± 0.02 
VE (L/min)* 88.2 ± 9.2 78.3 ± 8.5 80.9 ± 8.9 87.2 ± 7.6 
20 
VO2 (L/min) 3.5 ± 0.4 3.2 ± 0.3 3.3 ± 0.3 3.3 ± 0.3 
VO2 (mL/kg/min) 50.5 ± 1.5 45.9 ± 3.1 48.1 ± 2.5 48.4 ± 2.3 
RER 0.95 ± 0.02 0.92 ± 0.03 0.92 ± 0.03 0.92 ± 0.03 
VE (L/min) 110.4 ± 12.6 92.2 ± 10.6 † 97.2 ± 12.0 96.8 ± 8.4 
22:30 
VO2 (L/min) 3.5 ± 0.4 3.5 ± 0.4 3.5 ± 0.4 3.5 ± 0.4 
VO2 (mL/kg/min) 50.6 ± 2.3 49.7 ± 3.2 50.8 ± 2.8 49.8 ± 3.4 
RER 1.02 ± 0.03 1.03 ± 0.03 1.02 ± 0.04 1.01 ± 0.03 
VE (L/min) 127.2 ± 15.2 123.5 ± 16.34† 122.6 ± 15.6 129.7 ± 19.1 
* p < 0.05 compared to EXP; 
†









Heart Rate and Ratings of Perceived Exertion (RPE) 
Changes in HR (beats per minute) before and after 21 days of supplementation 
were not different between PLA and EXP, the exception of minute nine into recovery 
from exercise.  Average HR is displayed in Table 4.5.  Similarly, changes in RPE before 
and after 21 days of supplementation were not different between PLA and EXP.  Average 
RPE is displayed in Table 4.5. 
 
Table 4.5 Heart Rate and RPE Before and Following Supplementation 
  Placebo Experimental 
Time (min) Variable Pre Post Pre Post 
10 
HR (bpm) † 169 ± 6 166 ± 5† 168 ± 6 170 ± 7 
RPE 14.8 ± 0.5 15.2 ± 0.7 14.8 ±  0.8 15.0 ± 0.3 
20 
HR (bpm) 175 ± 4 173 ± 5 175 ±  5 175 ± 6 




 185 ± 4 182 ± 4 184 ± 5 184 ± 5 
RPE 19.2 ± 0.6 18.8 ± 0.5 19.0 ±  0.3 18.6 ± 0.4 
3R HR (bpm) 118 ± 6 111  ± 7 112 ± 50 118 ± 53 
6R HR (bpm) 105 ± 4 101 ± 6 109 ± 49 107 ± 48 
9R HR (bpm)* 107 ± 4 105 ± 5 103 ± 46 107 ± 48 
12R HR (bpm) 107 ± 5 103 ± 4^ 106 ± 6 106 ± 6 
* p < 0.05 compared to PLA; 
†
 p < 0.10 compared to EXP; ^ average ± SE with 4 of the 5 









Changes in blood flow (L/min) before and after 21 days of supplementation were 
not different between PLA and EXP (difference in pre- to post- supplementation PLA: 
1.1 ± 5.7 mL/min; difference in pre- to post- supplementation EXP: -1.7 ± 1.8).  Average 
blood flow is displayed in Table 4.6. 
 
Table 4.6 Blood Flow (L/min) 
 PLA EXP 








0.9 ± 0.4 1.2 ± 0.5 0.9 ± 0.4^ 1.1 ± 0.4^ 
Post 
Supplementation 
1.0 ± 0.4 1.4 ± 0.6 0.8 ± 0.5^ 1.4 ± 0.6^ 





 The primary aim of this study was to investigate the effects of herbal 
supplementation on exercise performance and central nervous system fatigue.  To 
compliment the primary measures and to gain insight into the physiological changes with 
herbal supplementation, blood glucose, blood lactate, VO2, RER, VE, HR, RPE and 
blood flow were also assessed.  Contrary to our hypothesis, the herbal treatment (EXP) 
had no effect on cycling performance or central nervous system fatigue.  Further, EXP 
had little effect on the aforementioned physiological parameters.  Noteworthy is a greater 
elevation from baseline in heart rate, VO2, ventilation, blood glucose, and blood lactate at 
minute 10 during the 20-minute fixed intensity workload, after 21- days of SR2W-1 
supplementation, but were all similar between treatments at 20-minutes.  This suggests 
that it took longer for subjects to physiologically adjust to the assigned workload after 
supplementing with EXP.  Collectively, the current preliminary data indicates 21 days of 
EXP supplementation did not confer any performance or physiological benefits. 
 The performance findings in the current study are substantiated by two 
comparable investigations, as they reported that one to eight weeks of herbal 
supplementation did not influence cycling time to fatigue (20, 21).  With a 400mg/d of 
herbal supplementation for eight weeks, Engels et al. found no effect on time to fatigue 
during a supramaximal Wingate Cycling protocol (20).  Eschbach et al. also reported no 
effect on time to fatigue, with one week of 1200mg/day (21).  Additional research on 
herbal supplementation and exercise performance has also shown no difference in 
exercise performance following supplementation (3, 6, 14, 18).  Although performance 
was not enhanced by herbal supplementation in the aforementioned studies, this finding 




swimming time to exhaustion in mice (1).  To our knowledge, only one study reported 
that performance is enhanced with herbal supplementation in humans (31).  The authors 
reported that cycling time trial performance was augmented following 5 weeks of 
supplementation (31).  A common aspect of the studies reporting positive effects on 
exercise performance seems to be duration of the herbal supplementation period.  A 
duration ranging between 8 days to 5 weeks have shown positive results (1, 5, 31), 
however there were a few studies with similar supplementation periods that reported null 
findings (3, 6, 14, 18). 
 In contrast to the current results, there is fairly strong evidence that herbal 
supplementation can favorably influence blood lactate levels during recovery from 
exercise (31, 43, 64).  However, several other studies have failed to confirm this effect (3, 
18, 21).  Specifically, Allen et al. and Earnest et al. both found no differences in recovery 
lactate levels with 2-3 weeks of herbal supplementation (3, 18).  Results in favor of 
herbal supplementation demonstrate reduced recovery lactate in as little as two weeks 
(1000mg/day of SR2W-1), with even further reductions in recovery lactate with two 
weeks of additional supplementation (43).  Additionally, Wu et al. was able to provide 
evidence that reduction in lactate levels during recovery from exercise were actually 
accelerated with 800mg/day of herbal supplementation (64).  These findings demonstrate 
the effectiveness of herbal aids on blood lactate recovery from exercise and potentially 
exercise performance. 
 An abundance of research supports the performance benefits of lower lactate and 
high pH levels, most of which has been elicited by induced alkalosis.  In general, with the 




enhanced and muscle fatigue attenuated compared to normal conditions (26, 45, 60, 63).  
In context, considering that levels were similar between EXP and PLA, it is not 
surprising that exercise performance was unaffected by EXP.  This is despite marked 
muscle fatigue independent of the treatment. 
Although 21-days of PLA and EXP supplementation had no differential impact on 
the physiological response to exercise, alterations in blood glucose between PLA and 
EXP, consistently approached significance at several different time points during the 
exercise trials (p < 0.10).  In addition to blood glucose, VE, VO2 and HR were also 
visually elevated during the fixed intensity ride following EXP.  In contrast to our general 
hypotheses, these findings provide some evidence that the same standardized protocol 
presented more of a physiological challenge following EXP supplementation.  This 
heightened physiological state could be attributed to a relatively long supplementation 
period, thereby exposing possible side effects of herbal supplementation if taken in 
excess.  However, other research failed to observe side effects with 3-5 weeks of SR2W-
1 supplementation (1, 31). 
To our knowledge, we are the first to assess post-exercise peripheral blood flow in 
response to herbal supplementation, and no differences were detected between PLA and 
EXP conditions.  There is a clear association between exercise intensity and post-exercise 
blood flow (7, 12, 23, 44).  For instance, Calbet et al. demonstrated that blood flow and 
vessel diameter increase in linearity with exercise intensity in both the upper and lower 
body extremities (12).  Although associated with lactate clearance, research is equivocal 




current study, the consistent post-exercise lactate dynamics with both PLA and EXP may 
be related to the similarities in blood flow between treatments. 
Despite the encouraging nature of early reports on the effects of herbal 
supplementation on exercise performance and blood lactate levels, the general 
performance and physiological response to exercise in the current study was similar 
under both PLA and EXP conditions.  It is worth mentioning that a major limitation of 
the current study is the small sample size (n = 5); however each subject acted as their 
own control, thereby eliminated the possibility of inter-group differences in subject 
characteristics.  Nonetheless, the current project is severely underpowered from a 
statistical standpoint and despite the apparent lack of benefits conferred by the herbal 
supplement, it possible a larger sample size would yield different results.  Regardless, the 
current study indicates that SR2W-1 has no impact on cycling performance and central 





The primary aim of this study was to examine the potential effects of 21-days of 
SR2W-1 supplementation on cycling performance, muscle fatigue, and various other 
physiological parameters (i.e. blood lactate, HR, RER, VE, VO2) with a randomized, 
double-blinded, crossover study design.  We hypothesized that SR2W-1 supplementation 
will: 1) improve time to fatigue compared to a placebo supplement, 2) elicit lower lactate 
levels during the cycling protocol and during the recovery period in comparison to 
placebo supplementation, 3) allow for better resistance to central fatigue after a bout of 
high-intensity cycling, in comparison to a placebo group, and 4) allow for better 
resistance to peripheral fatigue after a bout of high-intensity cycling, in comparison to a 
placebo group. 
 In contrast to our hypotheses, SR2W-1 was found to be ineffective in both 
improving in cycling performance and attenuating muscle fatigue.  Additionally, there 
were no differences in blood lactate, blood flow, RER, RPE, VO2 between the treatments.  
Noteworthy, are trends in elevated HR and VE throughout the 20-minute fixed-intensity 
cycling protocol, favoring EXP.  Possible explanations for lack of effect include, but are 
not limited to, a shorter supplementation period, short duration of cycling protocol and a 
small sample size.  Notwithstanding these limitations, results of the present study suggest 
that herbal supplementation with SR2W-1 is not needed to reach optimal levels of 




Appendix I          
CYCLISTS WANTED 
FOR 
SPORTS SUPPLEMENT STUDY 
 
The Human Performance Laboratory at JMU will be conducting a study examining the 
effects of an herbal sports supplement on cycling performance, muscle function, and 
lactate dynamics.     
Who are we looking for? 
-   Males and Females 
 
-   18-55 years old 
 
-   Cyclists (individuals performing cycling exercise on a regular basis – at least 3 x wk) 
 
What you will be asked to do: 
-   Complete preliminary fitness testing/screening (60-90 minutes) 
-   Participate in 5 exercise protocols (60-90 minutes), each of which consists of a 3 
minute warm-up, 20-minutes of hard riding, 3 x 1-minute high intensity intervals, 15 
minutes of recovery, and a high intensity ride to fatigue lasting approximately 5 
minutes (~30-35 of total exercise) 
-   Receive laboratory assessments (including small blood draws, a muscle function test 
or small muscle biopsy) during each trial 
-   Supplement for 21 days with an all-natural sports formula and a placebo (each 21-day 
supplementation period is separated by 10 days) 
 
What are the benefits of participation? 
-   Free evaluation of aerobic capacity (VO2max) and physiological data  
-   $150 to $250 (biopsy subjects) for study completion 
 






James Madison University 
Department of Kinesiology 
Consent for Investigative Procedure 
 
Purpose 
You are being asked to volunteer for a research project conducted by Dr. Nick Luden, Dr. Michael 
Saunders, Dr. Christopher Womack, Kevin Murach, and Tara Ata from James Madison University titled 
“The Effects of an Herbal Supplement on Human Cycling Performance, Muscle Function, and Lactate 
Dynamics”.   
The primary aim of the current project is to examine the influence that 21-days of SR2W-1 sports formula 
supplementation has on cycling performance, muscle function, and lactate dynamics.  Information gained 
from this project will help determine the efficacy of SR2W-1 as well as indicate the underlying changes 
that are responsible for gains in cycling performance.   
 
Experimental Procedures 
You will be asked to report to James Madison University‟s Human Performance Laboratory (Godwin 209) 
for a total of six trials.  Specifically, you will be asked to report to the laboratory for one pre-
testing/screening trial, one familiarization trial, and four treatment trials.  Each of the six trials will last 
approximately 60-90 minutes in duration.  Detailed information for each of these trials is provided below: 
 
Pre-testing/Screening (n = 1 trial) 
 
Before any physical evaluation is given, pre-screening forms will be completed to ensure that you meet the 
study criteria, that you do not have any risk factors for heavy exercise, and that you do not have any known 
allergies to local anesthesia.   In the process of filling out these forms, you will be asked to share 
information regarding your general health and lifestyle with the researchers.   If you meet the criteria for 
the study, the researchers will measure your height and weight and you will perform a cardiorespiratory 
fitness test.  During this assessment, an exercise test will be conducted to determine your maximal oxygen 
uptake (VO2max).  To do this, you will ride a stationary cycle at an initial workload that is „fairly easy‟.   
Workload will be increased every few minutes during the test.   You will be encouraged to continue to 
cycle until you request to stop due to fatigue or are unable to continue at a cadence >50 revolutions per 
minute.   Finger sticks to obtain blood for analysis of glucose and lactate will be taken every two minutes 
during exercise until fatigue.  In order to be included as a participant in the study, you must achieve a 
VO2peak of ≥ 40 ml/kg/min if female or ≥ 45 ml/kg/min if male.   If you meet these criteria, you will be 








Familiarization Trial: (n = 1 trial) 
Within 14 days of the pre-testing trial, you will be asked to report to the laboratory for a familiarization 
trial.  This trial will be identical to the treatment trials, with the exception that no blood or muscle biopsy 
samples will be taken.  Please see the detailed description of the treatment trials for a more complete 
understanding of the familiarization trial, noting again that no blood or muscle biopsy samples will be 
taken.     
 
Treatment Trials: (n = 4 trials) 
 
Within 5-14 days of the familiarization trial, you will be asked to perform the first of four treatment trials 
(TT).  The treatment trials will take place before and after 21 days of sports formula supplementation and 
before and after 21 days of placebo supplementation.  You will be randomly assigned to receive either 1000 
mg/day of SR2W-1 or 1000 mg/day of placebo.   The SR2W-1 supplement is an all-natural sports formula 
comprised of herbal and fungi extracts and the placebo capsule will look identical but will be filled with 
flour.   You will be asked to ingest 2 x 500 mg capsules every morning for 21 days.  To confirm 
compliance to supplementation, you will be asked to text, e-mail, or call a specified member of the 
investigative team once a day after the second ingestion (42 separate contacts).  Ten days following the first 
21-day supplementation period (and treatment trial) you will be asked to replicate the first portion of the 
study with the alternative supplement (placebo or SR2W-1).   See next page for a general study schematic.    
For each treatment trial, you will be asked to report to the laboratory in the morning after 10-12 hours of 











Each trial will last approximately 60-90 minutes in duration with the exercise protocol (shown below) 
lasting approximately 50 minutes.   Following a 3-minute warm-up, you will ride for 20-minutes at a hard 
intensity (approximately 85% VO2peak), upon which you will be asked to complete 3 x 1 minute intervals at 
an intensity associated with your VO2peak (determined during the pre-testing trial).   Each of these intervals 
will be separated by 30 seconds of riding at the same intensity as the preceding 20-minute ride.   Following 
the final interval you will be provided with 15 minutes of recovery.   The recovery phase will be followed 
by a ride until fatigue performed at an intensity associated with your VO2peak.   You are encouraged to treat 
this aspect of the trial as if it is a competitive event and to ride until you voluntarily stop or until you can no 













21-Day Supplementation Period 2 
 









A catheter will be inserted into a vein in the upper forearm approximately 10 minutes prior to the exercise 
protocol.   15 blood draws will be performed at various timepoints during the protocol and the catheter will 
remain in place until after the final blood draw.   The catheter minimizes the number of times that a needle 
is inserted.   During each sample, small amounts of blood (~3 milliliters) will be obtained and utilized to 
measure lactate, pH, and glucose.  The total amount of blood obtained during each trial will be 
approximately 39 ml or 180 ml over the course of the entire study.  This amount is similar to 50% of a can 
of soda or 38% of the amount given when donating blood in a single session.   
 
Metabolic Measurements 
Metabolic measurements such as oxygen uptake, ventilation, etc. will be measured using a SensorMedics 
metabolic cart.   To do this, you will be asked to breathe through a mouthpiece/breathing apparatus that 
collects your expired breath during the entire 20-minute fixed-intensity ride. 
 
Ratings of Perceived Exertion 
You will be asked to provide subjective ratings of your exertion level at various timepoints throughout the 
exercise protocol.   You will do this by pointing to your corresponding level of exertion (rated numerically 
from 6-20) on a Borg RPE scale.    
 
Heart Rate 
Your heart rate will be measured using a Polar heart rate monitor that will be worn around your chest 
during each exercise session.    
 
Skeletal Muscle Circulation 
During the 15-minute recovery period, thigh blood flow may be measured with ultrasound equipment – 
similar to what is done during fetal examinations during pregnancy.   Ultrasound gel will be applied to your 





In addition to the measures outlined above, you are being asked to volunteer for either a muscle 
function - central fatigue test OR a thigh muscle biopsy, as described below.   The muscle function-
central fatigue test will be performed during the familiarization trial and each treatment trial, while 
the muscle biopsy will only be performed during each treatment trial. 
 
 
Muscle Function – Central Fatigue Test 
 
You will be asked to complete a maximal strength test prior to each trial, immediately following the 3 x 1-
minute intervals and towards the end of the 15-minute recovery period.  During this test, you will be seated 
in a modified chair, and asked to push as hard as possible against a shin pad that will be connected to a 
force transducer for 4 repetitions with a minute rest in between.   During this strength test, you will also 
perform an electrically stimulated contraction.  Two adhesive patches will be placed on the skin of your 
thigh.   These electrodes will be used to apply electrical stimulation to the thigh muscle at an intensity, 
which produces a contraction force equal or greater to what you can generate on your own.  The stimulation 
intensity will be set below the maximum stimulation intensity you can tolerate, similar to a TENS unit used 
in physical therapy. 
 
 





A total of 4 muscle biopsies (one biopsy during each treatment trial) from the thigh will be obtained for this 
study protocol.  Prior to each biopsy, the skin at the biopsy site will be cleaned with povidone-iodine 
topical anti-septic and numbed by an injection of a local anesthetic (similar to what is done at the dentist).  
When the area is numb (5 minutes), a small 1/4 inch incision will be made in the skin and a needle will be 
inserted briefly (2-3 seconds) into the muscle to remove a piece of muscle about the size of a pea.  The 
incision will be pulled closed with a band-aid and the area over the incision will be covered with an elastic 
pressure bandage.  The entire procedure will take a total of approximately 10-15 minutes, with the actual 
biopsy lasting only a few seconds.   
 
 
________    I agree to participate in the muscle biopsy procedure 
 
 
Dietary and Exercise Controls   
You are to maintain consistent dietary habits for 72 hrs prior to each trial, and to complete a diet record (see 
Attachment 4) for the 24 hrs preceding each trial.  While avoiding heavy exercise for 48 hrs prior to each 
trial, you will also be asked to maintain consistent physical activity habits starting 72 hrs prior to the first 
treatment trial until the completion of the final treatment trial (~55 days), and to record all physical activity 
performed during the 72 hrs preceding each trial (see Attachment 5).  You are to consume your final „self-
selected‟ meal no less than 10 hrs prior to the start of the treatment trials (i.e. dinner on the evening prior to 
testing).   After this time, you are to consume only water ad libitum until the end of each treatment trial (a 







You are expected to be honest about disclosing all known risk factors to the researcher.  There are no 
known risks associated with supplementing with the SR2W-1 sports formula.  However, there are some 
risks associated with high does of some ingredients in isolation. SR2W-1 is a proprietary blend of herbs 
and fungi (primary ingredients: Enoki Mushroom, Eluthero Extract, Reishi Mushroom, Tangerine Extract, 
Cordyceps Mushroom, and Asian Ginseng). Although highly unlikely, it is possible that one or more of the 
ingredients can adversely impact pathophysiological conditions (blood clotting disorders such as 
hemophilia or thrombocytopenia) or medications (Coumadin, digoxin/digitalis).  You will be pre-screened 
for each of the aforementioned conditions as well as for known allergies to the ingredients.  You will also 
be provided with an adverse event/side effect form for you to record any adverse effects of 
supplementation. 
According to the American College of Sports Medicine, the risks associated with maximal exercise/testing 
for healthy individuals are very minimal.   If you do not meet the criteria for “low risk”, you will not be 
allowed to participate in the study.   In the unlikely event of cardiac or other complications during exercise, 
an emergency plan is in place.   This includes immediate access to a phone to call emergency personnel.   
In addition, each of the investigators is CPR certified.    
The exercise protocol may result in minor-moderate levels of muscle soreness and fatigue for 1-2 days 
following each exercise session.   However, the level of muscle soreness is expected to be lower than levels 
normally experienced when people perform other „normal‟ activities that are not part of their regular 
exercise routine (i.e. if a cyclist played a game of basketball with friends for 2 hours).   
The risks of blood draws include possible mild bruising, and the risk of transfer of blood-borne pathogens.   
This risk is considered to be very minimal, and all safety precautions for handing blood samples will be 
followed according to OSHA protocols.   The investigators have been trained in phlebotomy and completed 
JMU blood-borne pathogen training.   
 
The risks of the interpolated twitch technique include temporary “tingling” or “pulsing” sensation (for 1-2 
seconds), which you may perceive as uncomfortable.   
 
The risks associated with the muscle biopsy technique include a possible dull pain during the 
administration of the anesthetic and the biopsy procedure, and delayed soreness for one to two days 
following the biopsy.  Sterile procedures will be used during the biopsy procedure to minimize these risks.  
There is a small risk of bleeding, infection, and scarring of the skin.   Temporary numbness of the skin near 
the biopsy site occurs rarely.  You may feel lightheaded and there is a slight risk of fainting.  Following the 
biopsy you will be provided with a „biopsy care package‟ that will include instructions for care, band-aids, 
and alcohol pads.  As a precaution, a member of our research team will contact you via phone or e-mail 
approximately 48-hrs following the biopsy to confirm that you are recovering/healing from the biopsy 
appropriately.  You are also encouraged to contact a member of our research team if you have any concerns 
about your recovery.   There is a small risk of an allergic reaction to the local anesthetic used during the 
muscle biopsy procedure.   Symptoms may include an itching sensation of the skin, difficulty breathing, 
fainting, and shock.  Allergic reactions to the local anesthetic used are extremely rare.   You will be pre-
screened, as part of the medical history document, for any known allergic reaction to local anesthetics.   
Benefits 
The benefits associated with this project include a free VO2max assessment, and a $150 payment for study 
completion.   If you volunteered to undergo the muscle biopsy procedure you will receive an additional 




study, payments will be pro-rated as follows: non-biopsy subjects = $37.50 for the completion of each 
treatment trial, biopsy subjects = $62.50 for the completion of each treatment trial.    
 
Inquiries 
If you have any questions of concerns, please contact Dr. Nicholas Luden at ludennd@jmu.edu or (540) 
568-4069.   In the case of any immediate concerns or adverse reactions during the study, contact Dr. Luden 
on his cell phone (540) 746-6134.   
 
Confidentiality 
All data and results will be kept confidential.  You will be assigned an identification code.   At no time will 
your name be identified with your individual data.   The researcher retains the right to use and publish non-
identifiable data.   All data will be kept secured in a locked cabinet.   Final aggregate results will be made 
available to participants upon request.    
 
Freedom of Consent 
Your participation is entirely voluntary.   You are free to choose not to participate.   Should you choose to 
participate, you can withdraw at any time without consequences of any kind. 
 
I have read this consent form and I understand what is being requested of me as a participant in this study.   
I freely consent to participate.   I have been given satisfactory answers to my questions.   The investigator 
provided me with a copy of this form.   I certify that I am at least 18 years of age. 
 
   
Name of Subject  (Printed)  Name of Researcher  (Printed) 
   
Name of Subject  (Signed)  Name of Researcher  (Signed) 
   
  Date    Date 
 
For questions about your rights as a research subject, you may contact the chair of JMU’s 





AHA/ACSM Health/Fitness Facility Pre-participation Screening Questionnaire 
Assess your health status by marking all true statements 
 
History 
You have had: 
   a heart attack 
   heart surgery 
   cardiac catheterization 
   coronary angioplasty (PTCA) 
   pacemaker/implantable cardiac 
   defibrillator/rhythm disturbance 
   heart valve disease 
   heart failure 
   heart transplantation 
   congenital heart disease 
 
Symptoms 
   You experience chest discomfort with exertion 
   You experience unreasonable breathlessness 
   You experience dizziness, fainting, or blackouts 
   You take heart medications 
 
Other Health Issues 
   You have diabetes 
   You have asthma or other lung disease 
   You have burning or cramping sensation in your lower  
   legs when walking short distances 
If you marked any of these statements 
in this section, consult your physician 
or other appropriate health care 
provider before engaging in exercise.  
You may need to use a facility with a 




   You have musculoskeletal problems that limit your  
   physical activity 
   You have concerns about the safety of exercise 




Cardiovascular risk factors 
 
   You are a man older than 45 years 
   You are a woman older than 55 years, have had a  
   hysterectomy, or are postmenopausal 
   You smoke, or quit smoking within the previous 6 months 
   Your blood pressure is > 140/90 mmHg 
   You do not know your blood pressure 
   You take blood pressure medication 
   Your blood cholesterol level is > 200 mg/dl 
   You do not know your cholesterol level 
   You have a close blood relative who had a heart attack or 
   heart surgery before age 55 (father or brother) or age 65 
       (mother or sister) 
   You are physically inactive (i.e. you get < 30 minutes of  
   physical activity on at least 3 days of the week) 





If you marked two or more of the 
statements in this section, you should 
consult your physician or other 
appropriate health care provider 
before engaging in exercise.  You 
might benefit from using a facility 
with a professionally qualified 






“Negative risk factors” 
 





   None of the above 
You should be able to exercise safely 
without consulting your physician or 
other appropriate health care provider 
in a self-guided program or almost any 






Subject Prescreening Information 
Please Complete the Following: 
 
Gender:  Male     Female    (circle one) 
 




Weight (lbs):  
 
Average Exercise Habits over the Past 2 Months: 
 
Avg. # days of exercise per week: 
 
Avg. # of days of aerobic exercise per week: 
    
Avg. # of days of cycling per week:   
 
Do you have a muscle or joint injury that precludes the completion of the exercise protocol?  
Do you currently use medications for relief of pain and/or soreness?  
 
 
Do you have a blood clotting disorder (haemophilia, thrombocytopenia, etc)? 
 
 
Do you currently use blood-thinning medications (Coumadin, etc)? 
 
 
Do you currently use cardiac medications (Digoxin, Digitalis, etc)? 
 
 




 Enoki Mushroom 
 Eleuthero Extract 
 Reishi Mushroom 







Are you a vegetarian? 
 
Are you allergic to local anesthetics (numbing agents) such as Lidocaine (Xylocaine, Novocain, etc)? 
 
Have you had Novocain administered at the dentist?
 
Appendix V  
24-HOUR DIET RECORD 
Subject number____________  Date______________  Day of Week______________ 
Adapted From:  Lee RD, Nieman DC. Nutritional Assessment. 2nd ed. United States of America: Mosby; 1996






     
     
     
     
     
     
     
     
     








INSTRUCTIONS FOR KEEPING YOUR 24-HOUR  FOOD RECORD 
 
Keep your record for three days per trial. You will include the day before, the day of, and 
the day after each trial.  Include all meals, snacks, nibbling, and beverages including 
water and cocktails 
 
1. Fill out the date and day of the week at the top of food record sheet 
 
2. Record the time you consumed your food and/or drink.  To be most accurate, fill 
out the food record as soon as you finish eating. 
 
3. List the first food and/or drink you consumed when you began your day and 
continue to record until you consume your last food and/or drink of your day 
(usually before bedtime) 
 
4. List each food and/or drink on a separate line 
 Example:  cereal with milk, cereal and milk should each be on separate lines                      
spaghetti, noodles and sauce should each be on separate lines 
 
  Combination foods:   
   List parts of food on separate lines 
   Include preparation method, quantity, and brand name of each food 
 Example:  Sandwich (4 oz healthy choice turkey, 2 slices Sara Lee   
 wheat bread, 1 tbsp Hellman’s light mayo, 2 oz Kraft American  
 cheese, 1 slice of red fresh tomato) 
   
5. Record the method of preparation 
  Example:  fried, baked, grille, salt, oil (olive, canola, corn, other) butter or  
margarine, spices, etc. 
 




  Do not record any food not eaten 
  Example:  made two cups of vegetables but ate half so you would record one  
   cup 
   
  Quantity of food and/or drink 
  Example:  cups, ounces, liters, grams, each, or other unit of measure 
  Example:  1 cup of vegetables, 4 ounces of meat, one medium apple 
 
7. Record brand name 
  Example:  fast food chain name and/or package name 
  Example:  Wendy’s, Betty Crocker, Lean Cuisine, Gatorade, Thomas Bagel 
 




USE THE FOLLOWING TO HELP DETERMINE PORTION SIZES AND TYPES OF FOODS 
                                      PLEASE SPECIFY 
Beverages 
Sugar or creamer? 
Regular or sugar-free? 
Alcohol content? 
Name of drink and ingredients (if mixed drink) 
Breads Butter or margarine added? 
Cereal/Milk 
Milk, sugar, or fruit added? 
The type of milk? (skim, 1%, 2%, whole) 
Cereal:  dry or cooked measure? 
Dairy 
Is yogurt fruited or plain? 
% fat of milk or yogurt? 
Indicate brand name of cheese substitute and/or     nondairy 
creamer. 
Desserts 
Whipped topping added? 
Frosting? 
Fat modified (i.e., reduced)? 
Sugar-free? 
Eggs 
Preparation method (scrambled, hard-boiled, etc)? 
Fat used in cooking? 
Fast Food 
What restaurant? 
If not a national fast food chain, describe food in detail 
Size order of fries?  Super-size? 
Extra toppings on sandwich? 
Fats/Oils 
Regular or salt-free? 
Stick, tub, or liquid margarine? 
Reduced calorie or diet product? 
Fish 
Water or oil packed (fresh or canned)? 
Baked or fried (With batter or without)? 
Type of fat added? 
Raw or cooked weight? 
Fruit 
Sweetened or unsweetened? 
Fresh, canned, or frozen? 
With or without skin? 
Meats 
Visible fat removed? 
Light or dark meat?  Raw or cooked? 
Sugars and 
Sweets 
Regular or reduced-calorie? 
Don‟t forget hard candy as well as chocolate. 
Vegetables 
Raw or cooked? 
Fresh, frozen, or canned? 
Low-sodium or regular? 





Helpful Hints with Portion Sizes 
 
 1 teaspoon (5 ml)  
o about the size of the top half / tip of your thumb  
 1oz (28g) 
o approximately inch cube of cheese  
o volume of four stacked dice  
o slice of cheese is about the size of a 3 1/2 inch computer disk  
o chunk of cheese is about as thick as 2 dominoes  
o 1 handful (palm) of nuts  
 2 ounces (57 g)  
o 1 small chicken leg or thigh  
o 1/2 cup of cottage cheese or tuna  
 3 ounces (85 g)  
o serving of meat is about the size of a deck of playing cards (3 exchanges)  
o the size of the palm of your hand 
o 1/2 of whole chicken breast  
o 1 medium pork chop  
o 1 small hamburger  
o unbreaded fish fillet  
 1/2 cup (118 ml)  
o fruit or vegetables can fit in the palm of your hand  
o about the volume of a tennis ball  
 1 cup (236 ml)  
o about the size of a woman's fist  
o breakfast cereal goes halfway up the side of a standard cereal bowl  
o broccoli is about the size of a light bulb  






Daily Activity Records 
Subject #    Trial #    Date:   
Date Type of Exercise Performed Duration of Exercise 
(minutes) 
Intensity of Exercise 
(use scale below) 
    
 
    
 
    
 
    
 
    
 
    
 
    
    
    
    





7 Very, very light 
8 
9 Very light 
10 
11 Fairly light 
12 




17 Very hard 
18 
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